GABP	B-protein
factors	I-protein
bind	O
to	O
a	O
distal	B-DNA
interleukin	I-DNA
2	I-DNA
(	I-DNA
IL-2	I-DNA
)	I-DNA
enhancer	I-DNA
and	O
contribute	O
to	O
c-Raf	B-protein
-mediated	O
increase	O
in	O
IL-2	B-protein
induction	O
.	O

Triggering	O
of	O
the	O
T-cell	B-protein
receptor-CD3	I-protein
complex	I-protein
activates	O
two	O
major	O
signal	O
cascades	O
in	O
T	B-cell_type
lymphocytes	I-cell_type
,	O
(	O
i	O
)	O
Ca2+-dependent	O
signal	O
cascades	O
and	O
(	O
ii	O
)	O
protein	B-protein
kinase	I-protein
cascades	O
.	O

Both	O
signal	O
cascades	O
contribute	O
to	O
the	O
induction	O
of	O
the	O
interleukin	B-DNA
2	I-DNA
(	I-DNA
IL-2	I-DNA
)	I-DNA
gene	I-DNA
during	O
T-cell	O
activation	O
.	O

Prominent	O
protein	B-protein
kinase	I-protein
cascades	O
are	O
those	O
that	O
activate	O
mitogen-activated	B-protein
protein	I-protein
(	I-protein
MAP	I-protein
)	I-protein
kinases	I-protein
.	O

We	O
show	O
here	O
that	O
c-Raf	B-protein
,	O
which	O
is	O
at	O
the	O
helm	O
of	O
the	O
classic	O
MAP-	O
Erk	B-protein
cascade	O
,	O
contributes	O
to	O
IL-2	B-protein
induction	O
through	O
a	O
distal	B-DNA
enhancer	I-DNA
element	I-DNA
spanning	O
the	O
nucleotides	O
from	O
positions	O
-502	O
to	O
-413	O
in	O
front	O
of	O
the	O
transcriptional	O
start	O
site	O
of	O
the	O
IL-2	B-DNA
gene	I-DNA
.	O

Induction	O
of	O
this	O
distal	B-DNA
IL-2	I-DNA
enhancer	I-DNA
differs	O
from	O
induction	O
of	O
the	O
proximal	B-DNA
IL-2	I-DNA
promoter-enhancer	I-DNA
,	O
since	O
it	O
is	O
induced	O
by	O
phorbol	O
esters	O
alone	O
and	O
independent	O
from	O
Ca2+	O
signals	O
.	O

In	O
DNA-protein	O
binding	O
studies	O
,	O
we	O
detected	O
the	O
binding	O
of	O
transcription	B-protein
factors	I-protein
GABP	B-protein
alpha	I-protein
and	I-protein
-beta	I-protein
to	O
a	O
dyad	B-DNA
symmetry	I-DNA
element	I-DNA
(	O
DSE	B-DNA
)	O
of	O
the	O
distal	B-DNA
enhancer	I-DNA
,	O
which	O
is	O
formed	O
by	O
palindromic	B-DNA
binding	I-DNA
sites	I-DNA
of	O
Ets-like	B-protein
factors	I-protein
.	O

Introduction	O
of	O
point	O
mutations	O
suppressing	O
GABP	O
binding	O
to	O
the	O
DSE	B-DNA
interfered	O
with	O
the	O
induction	O
of	O
the	O
distal	B-DNA
enhancer	I-DNA
and	O
the	O
entire	O
IL-2	B-DNA
promoter-enhancer	I-DNA
,	O
while	O
overexpression	O
of	O
both	O
GABP	B-protein
factors	I-protein
enhanced	O
the	O
IL-2	B-DNA
promoter-enhancer	I-DNA
induction	O
.	O

Overexpression	O
of	O
BXB	B-protein
,	O
a	O
constitutive	O
active	O
version	O
of	O
c-Raf	B-protein
,	O
and	O
of	O
further	O
members	O
of	O
the	O
Ras	B-protein
-	O
Raf	B-protein
-	O
Erk	B-protein
signal	O
cascade	O
exerted	O
an	O
increase	O
of	O
GABP	B-protein
-mediated	O
promoter-enhancer	O
induction	O
.	O

In	O
conjunction	O
with	O
previously	O
published	O
data	O
on	O
c-Raf	B-protein
-induced	O
phosphorylation	O
of	O
GABP	B-protein
factors	I-protein
(	O
E.Flory	O
,	O
A.	O
Hoffmeyer	O
,	O
U.Smola	O
,	O
U.R.Rapp	O
,	O
and	O
J.T.Bruder	O
,	O
J.Virol.70	O
:	O
2260-	O
2268	O
,	O
1996	O
)	O
,	O
these	O
results	O
indicate	O
a	O
contribution	O
of	O
GABP	B-protein
factors	I-protein
to	O
the	O
Raf	B-protein
-mediated	O
enhancement	O
of	O
IL-2	B-protein
induction	O
during	O
T-cell	O
activation	O
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLOGY	NULL
,	NULL
Aug.	NULL
1997	NULL
,	NULL
p.	NULL
4381-4389	NULL
0270-7306/97/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1997	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

17	NULL
,	NULL
No	NULL
.	NULL

8	NULL
GABP	NULL
Factors	NULL
Bind	NULL
to	NULL
a	NULL
Distal	NULL
Interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
Enhancer	NULL
and	NULL
Contribute	NULL
to	NULL
c-Raf-Mediated	NULL
Increase	NULL
in	NULL
IL-2	NULL
Induction	NULL
ANDRIS	NULL
AVOTS	NULL
,	NULL
**	NULL
ANGELIKA	NULL
HOFFMEYER	NULL
,	NULL
°	NULL
EGBERT	NULL
FLORY	NULL
,	NULL
``	NULL
ALEXANDER	NULL
CIMANIS	NULL
,	NULL
``	NULL
ULF	NULL
R.	NULL
RAPP	NULL
,	NULL
``	NULL
anp	NULL
EDGAR	NULL
SERFLING'*	NULL
Department	NULL
of	NULL
Molecular	NULL
Pathology	NULL
,	NULL
Institute	NULL
of	NULL
Pathology	NULL
and	NULL
Institute	NULL
of	NULL
Medical	NULL
Radiation	NULL
Research	NULL
and	NULL
Cell	NULL
Biology	NULL
,	NULL
``	NULL
University	NULL
of	NULL
Wiirzburg	NULL
,	NULL
D-97080	NULL
Wiirzburg	NULL
,	NULL
Germany	NULL
,	NULL
and	NULL
Biomedical	NULL
Research	NULL
and	NULL
Study	NULL
Center	NULL
,	NULL
University	NULL
of	NULL
Latvia	NULL
,	NULL
LV-1067	NULL
Riga	NULL
,	NULL
Latvia®	NULL
Received	NULL
14	NULL
January	NULL
1997/Returned	NULL
for	NULL
modification	NULL
21	NULL
February	NULL
1997/Accepted	NULL
29	NULL
April	NULL
1997	NULL
Triggering	NULL
of	NULL
the	NULL
T-cell	NULL
receptor-CD3	NULL
complex	NULL
activates	NULL
two	NULL
major	NULL
signal	NULL
cascades	NULL
in	NULL
T	NULL
lymphocytes	NULL
,	NULL
(	NULL
i	NULL
)	NULL
Ca**-dependent	NULL
signal	NULL
cascades	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
protein	NULL
kinase	NULL
cascades	NULL
.	NULL

Both	NULL
signal	NULL
cascades	NULL
contribute	NULL
to	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
gene	NULL
during	NULL
T-cell	NULL
activation	NULL
.	NULL

Prominent	NULL
protein	NULL
kinase	NULL
cascades	NULL
are	NULL
those	NULL
that	NULL
activate	NULL
mitogen-activated	NULL
protein	NULL
(	NULL
MAP	NULL
)	NULL
kinases	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
c-Raf	NULL
,	NULL
which	NULL
is	NULL
at	NULL
the	NULL
helm	NULL
of	NULL
the	NULL
classic	NULL
MAP-Erk	NULL
cascade	NULL
,	NULL
contributes	NULL
to	NULL
IL-2	NULL
induction	NULL
through	NULL
a	NULL
distal	NULL
enhancer	NULL
element	NULL
spanning	NULL
the	NULL
nucleotides	NULL
from	NULL
positions	NULL
-502	NULL
to	NULL
-413	NULL
in	NULL
front	NULL
of	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

Induction	NULL
of	NULL
this	NULL
distal	NULL
IL-2	NULL
enhancer	NULL
differs	NULL
from	NULL
induction	NULL
of	NULL
the	NULL
proximal	NULL
IL-2	NULL
promoter-enhancer	NULL
,	NULL
since	NULL
it	NULL
is	NULL
induced	NULL
by	NULL
phorbol	NULL
esters	NULL
alone	NULL
and	NULL
independent	NULL
from	NULL
Ca**	NULL
signals	NULL
.	NULL

In	NULL
DNA-protein	NULL
binding	NULL
studies	NULL
,	NULL
we	NULL
detected	NULL
the	NULL
binding	NULL
of	NULL
transcription	NULL
factors	NULL
GABPa	NULL
and	NULL
-B	NULL
to	NULL
a	NULL
dyad	NULL
symmetry	NULL
element	NULL
(	NULL
DSE	NULL
)	NULL
of	NULL
the	NULL
distal	NULL
enhancer	NULL
,	NULL
which	NULL
is	NULL
formed	NULL
by	NULL
palindromic	NULL
binding	NULL
sites	NULL
of	NULL
Ets-like	NULL
factors	NULL
.	NULL

Introduction	NULL
of	NULL
point	NULL
mutations	NULL
suppressing	NULL
GABP	NULL
binding	NULL
to	NULL
the	NULL
DSE	NULL
interfered	NULL
with	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
distal	NULL
enhancer	NULL
and	NULL
the	NULL
entire	NULL
IL-2	NULL
promoter-enhancer	NULL
,	NULL
while	NULL
overexpression	NULL
of	NULL
both	NULL
GABP	NULL
factors	NULL
enhanced	NULL
the	NULL
IL-2	NULL
promoter-enhancer	NULL
induction	NULL
.	NULL

Overexpression	NULL
of	NULL
BXB	NULL
,	NULL
a	NULL
constitutive	NULL
active	NULL
version	NULL
of	NULL
c-Raf	NULL
,	NULL
and	NULL
of	NULL
further	NULL
members	NULL
of	NULL
the	NULL
Ras-Raf-Erk	NULL
signal	NULL
cascade	NULL
exerted	NULL
an	NULL
increase	NULL
of	NULL
GABP-mediated	NULL
promoter-enhancer	NULL
induction	NULL
.	NULL

In	NULL
conjunction	NULL
with	NULL
previously	NULL
published	NULL
data	NULL
on	NULL
c-Raf-induced	NULL
phosphorylation	NULL
of	NULL
GABP	NULL
factors	NULL
(	NULL
E.	NULL
Flory	NULL
,	NULL
A.	NULL
Hoffmeyer	NULL
,	NULL
U.	NULL
Smola	NULL
,	NULL
U.	NULL
R.	NULL
Rapp	NULL
,	NULL
and	NULL
J.	NULL
T.	NULL
Bruder	NULL
,	NULL
J.	NULL
Virol	NULL
.	NULL

70:2260-2268	NULL
,	NULL
1996	NULL
)	NULL
,	NULL
these	NULL
results	NULL
indicate	NULL
a	NULL
contribution	NULL
of	NULL
GABP	NULL
factors	NULL
to	NULL
the	NULL
Raf-mediated	NULL
enhancement	NULL
of	NULL
IL-2	NULL
induction	NULL
during	NULL
T-cell	NULL
activation	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
transcription	NULL
is	NULL
a	NULL
hallmark	NULL
of	NULL
activation	NULL
of	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
.	NULL

It	NULL
is	NULL
initiated	NULL
by	NULL
the	NULL
interaction	NULL
of	NULL
processed	NULL
antigens	NULL
presented	NULL
in	NULL
the	NULL
context	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
proteins	NULL
with	NULL
the	NULL
T-cell	NULL
receptor	NULL
(	NULL
TCR	NULL
)	NULL
-CD3	NULL
complex	NULL
.	NULL

The	NULL
triggering	NULL
of	NULL
the	NULL
TCR	NULL
complex	NULL
instantly	NULL
induces	NULL
numerous	NULL
tyrosine	NULL
protein	NULL
phospho-rylations	NULL
and	NULL
an	NULL
immediate	NULL
increase	NULL
in	NULL
intracellular	NULL
Ca**	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
for	NULL
a	NULL
recent	NULL
review	NULL
,	NULL
see	NULL
reference	NULL
6	NULL
)	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
intracellular	NULL
Ca**	NULL
,	NULL
which	NULL
was	NULL
caused	NULL
by	NULL
an	NULL
influx	NULL
of	NULL
extracellular	NULL
Ca**	NULL
and	NULL
mobilization	NULL
of	NULL
Ca**	NULL
from	NULL
intracellular	NULL
stores	NULL
,	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
IL-2	NULL
expression	NULL
.	NULL

Inhibition	NULL
of	NULL
enzymatic	NULL
activity	NULL
of	NULL
the	NULL
Ca**	NULL
-calmodulin-depen-dent	NULL
phosphatase	NULL
calcineurin	NULL
by	NULL
the	NULL
immunosuppressants	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
and	NULL
FK506	NULL
inhibits	NULL
both	NULL
T-cell	NULL
activation	NULL
and	NULL
IL-2	NULL
expression	NULL
(	NULL
24	NULL
)	NULL
.	NULL

NF-AT	NULL
factors	NULL
,	NULL
which	NULL
bind	NULL
to	NULL
and	NULL
control	NULL
the	NULL
promoters	NULL
of	NULL
numerous	NULL
lymphokine	NULL
genes	NULL
in	NULL
T	NULL
lymphocytes	NULL
,	NULL
are	NULL
the	NULL
major	NULL
targets	NULL
of	NULL
Ca**-dependent	NULL
signaling	NULL
pathways	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
inactive	NULL
cytosolic	NULL
NF-AT	NULL
proteins	NULL
are	NULL
bound	NULL
by	NULL
calcineurin	NULL
,	NULL
de-phosphorylated	NULL
,	NULL
and	NULL
,	NULL
in	NULL
a	NULL
complex	NULL
with	NULL
calcineurin	NULL
,	NULL
translocated	NULL
into	NULL
the	NULL
nuclei	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
calcineurin	NULL
appears	NULL
to	NULL
stimulate	NULL
NF-AT-mediated	NULL
transcription	NULL
by	NULL
counteracting	NULL
an	NULL
NF-AT	NULL
protein	NULL
kinase	NULL
(	NULL
41	NULL
)	NULL
.	NULL

Prominent	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
(	NULL
PTKs	NULL
)	NULL
,	NULL
whose	NULL
activity	NULL
is	NULL
induced	NULL
by	NULL
triggering	NULL
the	NULL
TCR	NULL
complex	NULL
,	NULL
are	NULL
members	NULL
of	NULL
the	NULL
src	NULL
kinase	NULL
family	NULL
p56	NULL
``	NULL
~*	NULL
and	NULL
p59	NULL
``	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
syk-like	NULL
kinase	NULL
ZAP-70	NULL
(	NULL
6	NULL
)	NULL
.	NULL

One	NULL
downstream	NULL
,	NULL
indirect	NULL
target	NULL
of	NULL
PTKs	NULL
is	NULL
the	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Institute	NULL
of	NULL
Pathology	NULL
,	NULL
Josef-Schneider-Str	NULL
.	NULL

2	NULL
,	NULL
D-97080	NULL
Wiirzburg	NULL
,	NULL
Germany	NULL
.	NULL

Phone	NULL
:	NULL
49	NULL
0931	NULL
201	NULL
34	NULL
29	NULL
.	NULL

Fax	NULL
:	NULL
49	NULL
0931	NULL
201	NULL
34	NULL
29	NULL
(	NULL
or	NULL
34	NULL
40	NULL
)	NULL
.	NULL

4381	NULL
GTP-binding	NULL
protein	NULL
p21	NULL
``	NULL
*	NULL
``	NULL
.	NULL

Active	NULL
p21	NULL
``	NULL
``	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
essential	NULL
for	NULL
the	NULL
signal	NULL
transfer	NULL
from	NULL
the	NULL
TCR	NULL
to	NULL
the	NULL
nuclei	NULL
of	NULL
T	NULL
cells	NULL
,	NULL
resulting	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
promoter	NULL
(	NULL
6	NULL
)	NULL
.	NULL

c-Raf	NULL
is	NULL
a	NULL
direct	NULL
target	NULL
of	NULL
p21	NULL
``	NULL
and	NULL
becomes	NULL
transiently	NULL
translocated	NULL
to	NULL
the	NULL
cell	NULL
membrane	NULL
after	NULL
its	NULL
interaction	NULL
with	NULL
Ras	NULL
(	NULL
see	NULL
reference	NULL
32	NULL
for	NULL
a	NULL
review	NULL
)	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
triggering	NULL
of	NULL
the	NULL
TCR	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
c-Raf	NULL
(	NULL
26	NULL
,	NULL
42	NULL
)	NULL
and	NULL
Erk-2	NULL
(	NULL
14	NULL
,	NULL
51	NULL
)	NULL
,	NULL
an	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
of	NULL
the	NULL
mitogen-activated	NULL
protein	NULL
(	NULL
MAP	NULL
)	NULL
kinase	NULL
family	NULL
.	NULL

Other	NULL
members	NULL
of	NULL
the	NULL
family	NULL
of	NULL
MAP	NULL
kinases	NULL
which	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
are	NULL
the	NULL
JNK-SAP	NULL
kinases	NULL
.	NULL

Like	NULL
the	NULL
induction	NULL
of	NULL
IL-2	NULL
synthesis	NULL
,	NULL
the	NULL
triggering	NULL
of	NULL
Jurkat	NULL
cells	NULL
through	NULL
the	NULL
TCR-CD3	NULL
complex	NULL
and	NULL
CD28	NULL
coreceptor	NULL
resulted	NULL
in	NULL
a	NULL
CsA-sensitive	NULL
induction	NULL
of	NULL
JNK	NULL
activity	NULL
(	NULL
43	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
JNK/SAP	NULL
kinases	NULL
in	NULL
IL-2	NULL
induction	NULL
.	NULL

The	NULL
promoters	NULL
of	NULL
human	NULL
and	NULL
murine	NULL
IL-2	NULL
genes	NULL
have	NULL
been	NULL
studied	NULL
extensively	NULL
and	NULL
are	NULL
defined	NULL
as	NULL
DNA	NULL
segments	NULL
of	NULL
approximately	NULL
275	NULL
bp	NULL
whose	NULL
activity	NULL
determines	NULL
faithful	NULL
IL-2	NULL
expression	NULL
(	NULL
see	NULL
reference	NULL
39	NULL
for	NULL
a	NULL
recent	NULL
review	NULL
)	NULL
.	NULL

The	NULL
IL-2	NULL
promoter	NULL
harbors	NULL
several	NULL
binding	NULL
sites	NULL
for	NULL
transcription	NULL
factors	NULL
which	NULL
control	NULL
T-cell-restricted	NULL
induction	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
.	NULL

Prominent	NULL
transacting	NULL
factors	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
are	NULL
the	NULL
NF-AT-	NULL
,	NULL
NF-	NULL
«	NULL
B-	NULL
,	NULL
octamer-	NULL
,	NULL
and	NULL
AP-1-like	NULL
factors	NULL
.	NULL

Although	NULL
all	NULL
of	NULL
these	NULL
factors	NULL
are	NULL
also	NULL
expressed	NULL
in	NULL
nonlymphoid	NULL
cells	NULL
,	NULL
NF-AT	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
factors	NULL
are	NULL
expressed	NULL
in	NULL
higher	NULL
concentrations	NULL
in	NULL
lymphoid	NULL
cells	NULL
.	NULL

The	NULL
enhanced	NULL
levels	NULL
and	NULL
the	NULL
predominant	NULL
Ca**-dependent	NULL
activation	NULL
of	NULL
NF-AT	NULL
factors	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
interplay	NULL
with	NULL
other	NULL
factors	NULL
,	NULL
result	NULL
in	NULL
a	NULL
strong	NULL
T-cell-specific	NULL
induction	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
.	NULL

Other	NULL
experimental	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
IL-2	NULL
promoters	NULL
do	NULL
not	NULL
harbor	NULL
all	NULL
of	NULL
the	NULL
sequence	NULL
elements	NULL
required	NULL
for	NULL
the	NULL
correct	NULL
transcriptional	NULL
control	NULL
of	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

In	NULL
only	NULL
1	NULL
4382	NULL
AVOTS	NULL
ET	NULL
AL	NULL
.	NULL

of	NULL
17	NULL
lines	NULL
of	NULL
transgenic	NULL
mice	NULL
carrying	NULL
IL-2	NULL
promoter-lacZ	NULL
reporter	NULL
genes	NULL
,	NULL
the	NULL
reporter	NULL
gene	NULL
was	NULL
induced	NULL
in	NULL
an	NULL
inducible	NULL
and	NULL
T-cell-specific	NULL
manner	NULL
(	NULL
3	NULL
)	NULL
.	NULL

This	NULL
implies	NULL
that	NULL
DNA	NULL
sequences	NULL
outside	NULL
the	NULL
IL-2	NULL
promoter	NULL
might	NULL
also	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
IL-2	NULL
expression	NULL
.	NULL

Such	NULL
sequences	NULL
could	NULL
correspond	NULL
to	NULL
the	NULL
DNA	NULL
segments	NULL
highly	NULL
conserved	NULL
between	NULL
humans	NULL
and	NULL
mice	NULL
,	NULL
which	NULL
span	NULL
up	NULL
to	NULL
2	NULL
kb	NULL
of	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
IL-2	NULL
genes	NULL
(	NULL
15	NULL
,	NULL
25	NULL
)	NULL
.	NULL

When	NULL
DNA	NULL
segments	NULL
from	NULL
this	NULL
region	NULL
of	NULL
the	NULL
murine	NULL
IL-2	NULL
gene	NULL
were	NULL
tested	NULL
in	NULL
transient	NULL
transfections	NULL
,	NULL
a	NULL
DNA	NULL
segment	NULL
spanning	NULL
the	NULL
nucleotides	NULL
from	NULL
-578	NULL
to	NULL
-321	NULL
(	NULL
-578/	NULL
-321	NULL
)	NULL
enhanced	NULL
induction	NULL
of	NULL
the	NULL
proximal	NULL
promoter-enhancer	NULL
25	NULL
)	NULL
.	NULL

(	NULL
121	NULL
this	NULL
study	NULL
,	NULL
we	NULL
show	NULL
that	NULL
a	NULL
DNA	NULL
segment	NULL
from	NULL
the	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
,	NULL
spanning	NULL
the	NULL
nucleotides	NULL
from	NULL
-502	NULL
to	NULL
-413	NULL
(	NULL
-502/-413	NULL
)	NULL
,	NULL
contains	NULL
an	NULL
inducible	NULL
transcriptional	NULL
enhancer	NULL
.	NULL

This	NULL
distal	NULL
enhancer	NULL
overlaps	NULL
with	NULL
a	NULL
DNase	NULL
I-hypersensitive	NULL
region	NULL
which	NULL
was	NULL
found	NULL
to	NULL
be	NULL
structurally	NULL
distorted	NULL
in	NULL
T	NULL
cells	NULL
but	NULL
not	NULL
in	NULL
other	NULL
cells	NULL
(	NULL
34	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
proximal	NULL
IL-2	NULL
promoter	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
distal	NULL
enhancer	NULL
is	NULL
stimulated	NULL
by	NULL
phorbol	NULL
esters	NULL
alone	NULL
,	NULL
whereas	NULL
an	NULL
increase	NULL
in	NULL
Ca**	NULL
had	NULL
a	NULL
marginal	NULL
effect	NULL
on	NULL
its	NULL
induction	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
the	NULL
distal	NULL
enhancer	NULL
is	NULL
controlled	NULL
by	NULL
the	NULL
transcription	NULL
factors	NULL
GABPa	NULL
and	NULL
-B	NULL
,	NULL
which	NULL
interact	NULL
with	NULL
two	NULL
Ets-like	NULL
binding	NULL
motifs	NULL
of	NULL
palindromic	NULL
configuration	NULL
.	NULL

Overexpression	NULL
of	NULL
several	NULL
active	NULL
members	NULL
of	NULL
the	NULL
Ras-Raf-Erk	NULL
signaling	NULL
cascade	NULL
stimulated	NULL
GABP-mediated	NULL
induction	NULL
of	NULL
the	NULL
distal	NULL
enhancer	NULL
,	NULL
while	NULL
overexpression	NULL
of	NULL
dominant-negative	NULL
members	NULL
of	NULL
this	NULL
signaling	NULL
cascade	NULL
interfered	NULL
with	NULL
GABP	NULL
-mediated	NULL
induction	NULL
of	NULL
the	NULL
distal	NULL
enhancer	NULL
.	NULL

These	NULL
and	NULL
further	NULL
data	NULL
concerning	NULL
Raf-mediated	NULL
phosphorylation	NULL
of	NULL
GABP	NULL
factors	NULL
(	NULL
10	NULL
)	NULL
and	NULL
increase	NULL
of	NULL
IL-2	NULL
secretion	NULL
(	NULL
26	NULL
)	NULL
indicate	NULL
that	NULL
the	NULL
GABP	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
distal	NULL
IL-2	NULL
enhancer	NULL
contribute	NULL
to	NULL
Ras-Raf-Erk-medi-ated	NULL
induction	NULL
of	NULL
IL-2	NULL
expression	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cells	NULL
,	NULL
DNA	NULL
transfections	NULL
,	NULL
CAT	NULL
assays	NULL
,	NULL
and	NULL
measurement	NULL
of	NULL
IL-2	NULL
secretion	NULL
.	NULL

Human	NULL
Jurkat	NULL
T	NULL
leukemia	NULL
cells	NULL
and	NULL
A	NULL
3.01	NULL
T	NULL
lymphoma	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
medium	NULL
supplemented	NULL
with	NULL
5	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
to	NULL
a	NULL
density	NULL
of	NULL
2	NULL
x	NULL
10°	NULL
cells	NULL
per	NULL
ml	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
transfected	NULL
according	NULL
to	NULL
a	NULL
standard	NULL
DEAE-dextran	NULL
transfection	NULL
protocol	NULL
(	NULL
30	NULL
)	NULL
or	NULL
the	NULL
DMRIE-C	NULL
(	NULL
GIBCO	NULL
)	NULL
transfection	NULL
protocol	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Cotransfections	NULL
were	NULL
done	NULL
with	NULL
cDNA	NULL
vectors	NULL
for	NULL
overexpression	NULL
of	NULL
dominant-negative	NULL
and	NULL
constitutive-active	NULL
versions	NULL
of	NULL
Ras	NULL
(	NULL
RasN17	NULL
and	NULL
v-H-Ras	NULL
,	NULL
respectively	NULL
)	NULL
(	NULL
2	NULL
)	NULL
and	NULL
Raf-1	NULL
(	NULL
C48	NULL
and	NULL
BXB	NULL
,	NULL
respectively	NULL
)	NULL
(	NULL
5	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
vector	NULL
for	NULL
Erk-2	NULL
as	NULL
well	NULL
as	NULL
the	NULL
SxTREcoll-tkCAT	NULL
and	NULL
4xTREjun-tkCAT	NULL
constructs	NULL
have	NULL
also	NULL
been	NULL
described	NULL
elsewhere	NULL
(	NULL
16	NULL
,	NULL
47	NULL
)	NULL
.	NULL

At	NULL
20	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
divided	NULL
.	NULL

One	NULL
part	NULL
of	NULL
the	NULL
cells	NULL
was	NULL
used	NULL
as	NULL
an	NULL
uninduced	NULL
control	NULL
,	NULL
while	NULL
the	NULL
other	NULL
parts	NULL
of	NULL
the	NULL
cultures	NULL
were	NULL
induced	NULL
for	NULL
20	NULL
to	NULL
24	NULL
h	NULL
as	NULL
indicated	NULL
in	NULL
the	NULL
figure	NULL
legends	NULL
(	NULL
e.g	NULL
.	NULL

,	NULL
see	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
cells	NULL
were	NULL
lysed	NULL
,	NULL
chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
assays	NULL
were	NULL
per-formed	NULL
,	NULL
and	NULL
the	NULL
percentages	NULL
of	NULL
acetylated	NULL
chloramphenical	NULL
were	NULL
measured	NULL
with	NULL
a	NULL
PhosphorImager	NULL
.	NULL

DNA	NULL
cloning	NULL
.	NULL

A	NULL
3.2-kb	NULL
EcoRI	NULL
fragment	NULL
spanning	NULL
the	NULL
nucleotides	NULL
from	NULL
positions	NULL
-1955	NULL
to	NULL
approximately	NULL
+1200	NULL
(	NULL
-1955/+1200	NULL
)	NULL
of	NULL
the	NULL
genomic	NULL
human	NULL
IL-2	NULL
gene	NULL
was	NULL
excised	NULL
from	NULL
the	NULL
lambda	NULL
clone	NULL
Charon	NULL
4A-IL32	NULL
(	NULL
15	NULL
)	NULL
and	NULL
used	NULL
for	NULL
the	NULL
construction	NULL
of	NULL
thymidine	NULL
kinase	NULL
(	NULL
tk	NULL
)	NULL
CAT	NULL
plasmids	NULL
with	NULL
pBLCATS3	NULL
(	NULL
2a	NULL
)	NULL
.	NULL

Plasmid	NULL
-499/+5	NULL
containing	NULL
the	NULL
proximal	NULL
and	NULL
distal	NULL
enhancers	NULL
was	NULL
synthesized	NULL
by	NULL
PCR	NULL
.	NULL

The	NULL
proximal	NULL
enhancer	NULL
construct	NULL
-326/+5	NULL
was	NULL
obtained	NULL
by	NULL
subsequent	NULL
digestion	NULL
with	NULL
XmnI	NULL
.	NULL

The	NULL
constructs	NULL
-583/-164	NULL
and	NULL
-583/-326	NULL
were	NULL
constructed	NULL
by	NULL
digestion	NULL
with	NULL
Real	NULL
(	NULL
cutting	NULL
at	NULL
-583	NULL
)	NULL
and	NULL
Drel	NULL
(	NULL
cutting	NULL
at	NULL
-164	NULL
)	NULL
or	NULL
XmnI	NULL
,	NULL
respectively	NULL
.	NULL

Plasmid	NULL
-583/+5	NULL
was	NULL
obtained	NULL
by	NULL
ligation	NULL
and	NULL
cloning	NULL
of	NULL
-326/+5	NULL
and	NULL
-583/-326	NULL
segments	NULL
into	NULL
The	NULL
distal	NULL
enhancer	NULL
segment	NULL
-502/-413	NULL
was	NULL
synthesized	NULL
by	NULL
PCR	NULL
followed	NULL
by	NULL
cloning	NULL
in	NULL
pBLCAT5	NULL
.	NULL

The	NULL
IL-2	NULL
segments	NULL
of	NULL
all	NULL
constructs	NULL
were	NULL
sequenced	NULL
.	NULL

The	NULL
following	NULL
constructs	NULL
containing	NULL
further	NULL
upstream	NULL
DNA	NULL
segments	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
were	NULL
obtained	NULL
by	NULL
cloning	NULL
of	NULL
DNA	NULL
restriction	NULL
fragments	NULL
:	NULL
-682/-582	NULL
,	NULL
Ddel	NULL
fragment	NULL
;	NULL
-913/-682	NULL
,	NULL
Ddel	NULL
fragment	NULL
;	NULL
-1018/-582	NULL
,	NULL
HindIWW/Xbel	NULL
fragment	NULL
;	NULL
-1018/-969	NULL
,	NULL
Mval	NULL
fragment	NULL
;	NULL
-1326/-1011	NULL
,	NULL
Hinfl	NULL
fragment	NULL
;	NULL
-1525/-1326	NULL
,	NULL
Hinfl	NULL
fragment	NULL
;	NULL
-1731/-1524	NULL
,	NULL
Hin	NULL
{	NULL
l/Seu3A	NULL
fragment	NULL
;	NULL
and	NULL
-1957/-1731	NULL
,	NULL
Sau3A	NULL
fragment	NULL
.	NULL

The	NULL
-1976/-1902	NULL
fragment	NULL
was	NULL
synthesized	NULL
by	NULL
PCR	NULL
.	NULL

Mutations	NULL
into	NULL
the	NULL
protein	NULL
binding	NULL
sites	NULL
of	NULL
the	NULL
distal	NULL
enhancer	NULL
(	NULL
-502/-413	NULL
)	NULL
or	NULL
the	NULL
entire	NULL
5	NULL
'	NULL
region	NULL
(	NULL
-499/+5	NULL
)	NULL
were	NULL
introduced	NULL
with	NULL
a	NULL
site-directed	NULL
mutagenesis	NULL
system	NULL
(	NULL
Amersham	NULL
[	NULL
version	NULL
2	NULL
]	NULL
)	NULL
and	NULL
the	NULL
following	NULL
oligonucleotides	NULL
:	NULL
Octy	NULL
,	NULL
(	NULL
-502	NULL
)	NULL
gattT	NULL
ATGCG	NULL
GTTAG	NULL
CTCAT	NULL
(	NULL
-487	NULL
)	NULL
;	NULL
GATAy	NULL
,	NULL
(	NULL
-489	NULL
)	NULL
CATTG	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

TGTCC	NULL
ATAAA	NULL
AAGGT	NULL
(	NULL
-470	NULL
)	NULL
;	NULL
ERE-Ay	NULL
,	NULL
(	NULL
-445	NULL
)	NULL
AATAC	NULL
ACTTG	NULL
GT	NULL
GTT	NULL
TAATC	NULL
(	NULL
-426	NULL
)	NULL
;	NULL
and	NULL
ERE-By	NULL
,	NULL
(	NULL
-461	NULL
)	NULL
T	NULL
CTGAA	NULL
ACACC	NULL
AAACC	NULL
AATA	NULL
(	NULL
-442	NULL
)	NULL
.	NULL

The	NULL
following	NULL
CAT	NULL
constructs	NULL
containing	NULL
multiple	NULL
copies	NULL
of	NULL
dyad	NULL
symmetry	NULL
element	NULL
(	NULL
DSE	NULL
)	NULL
and	NULL
Ets-related	NULL
element	NULL
(	NULL
ERE	NULL
)	NULL
motifs	NULL
were	NULL
con-structed	NULL
:	NULL
4xDSE	NULL
(	NULL
from	NULL
-424	NULL
to	NULL
-462	NULL
[	NULL
all	NULL
four	NULL
copies	NULL
cloned	NULL
in	NULL
the	NULL
Xbel	NULL
site	NULL
of	NULL
pBLCATS	NULL
opposite	NULL
to	NULL
the	NULL
direction	NULL
of	NULL
CAT	NULL
gene	NULL
transcription	NULL
]	NULL
)	NULL
,	NULL
4xDSE-A	NULL
,	NULL
,	NULL
(	NULL
all	NULL
copies	NULL
opposite	NULL
to	NULL
the	NULL
transcription	NULL
direction	NULL
)	NULL
,	NULL
4xDSE-B	NULL
,	NULL
,	NULL
,	NULL
(	NULL
the	NULL
most	NULL
proximal	NULL
and	NULL
distal	NULL
copies	NULL
in	NULL
the	NULL
orientation	NULL
of	NULL
transcription	NULL
and	NULL
the	NULL
two	NULL
inner	NULL
copies	NULL
in	NULL
the	NULL
opposite	NULL
orientation	NULL
)	NULL
,	NULL
4xDSE-A	NULL
,	NULL
,	NULL
+B	NULL
,	NULL
(	NULL
all	NULL
copies	NULL
in	NULL
the	NULL
direction	NULL
of	NULL
transcription	NULL
)	NULL
,	NULL
5xERE-A	NULL
DNA	NULL
(	NULL
from	NULL
-426	NULL
to	NULL
-445	NULL
[	NULL
cloned	NULL
in	NULL
the	NULL
Xbel	NULL
site	NULL
of	NULL
pBLCATS	NULL
in	NULL
the	NULL
orientation	NULL
of	NULL
transcription	NULL
]	NULL
)	NULL
,	NULL
SxERE-A	NULL
,	NULL
,	NULL
(	NULL
four	NULL
copies	NULL
in	NULL
the	NULL
direction	NULL
of	NULL
transcription	NULL
and	NULL
the	NULL
most	NULL
proximal	NULL
in	NULL
the	NULL
opposite	NULL
)	NULL
,	NULL
SXERE-B	NULL
(	NULL
from	NULL
-442	NULL
to	NULL
-461	NULL
[	NULL
all	NULL
copies	NULL
were	NULL
cloned	NULL
opposite	NULL
to	NULL
the	NULL
direction	NULL
of	NULL
transcription	NULL
]	NULL
)	NULL
,	NULL
and	NULL
ERE-B	NULL
,	NULL
,	NULL
,	NULL
(	NULL
copies	NULL
one	NULL
,	NULL
three	NULL
,	NULL
and	NULL
four-relative	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
site-were	NULL
cloned	NULL
in	NULL
the	NULL
direction	NULL
opposite	NULL
to	NULL
that	NULL
of	NULL
transcription	NULL
and	NULL
the	NULL
others	NULL
were	NULL
cloned	NULL
in	NULL
the	NULL
direction	NULL
of	NULL
transcription	NULL
)	NULL
.	NULL

DNA-protein	NULL
binding	NULL
and	NULL
other	NULL
analyses	NULL
.	NULL

Crude	NULL
nuclear	NULL
protein	NULL
extracts	NULL
were	NULL
prepared	NULL
according	NULL
to	NULL
the	NULL
method	NULL
described	NULL
by	NULL
Schreiber	NULL
et	NULL
al	NULL
.	NULL

(	NULL
37	NULL
)	NULL
,	NULL
with	NULL
the	NULL
exception	NULL
that	NULL
Nonidet	NULL
P-40	NULL
was	NULL
omitted	NULL
and	NULL
nuclei	NULL
were	NULL
prepared	NULL
by	NULL
passing	NULL
the	NULL
cells	NULL
10	NULL
times	NULL
through	NULL
an	NULL
injection	NULL
needle	NULL
(	NULL
26G3/8	NULL
)	NULL
.	NULL

In	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
,	NULL
4	NULL
pg	NULL
of	NULL
nuclear	NULL
proteins	NULL
was	NULL
preincubated	NULL
with	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI	NULL
»	NULL
dC	NULL
)	NULL
as	NULL
unspecific	NULL
competitor	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
.	NULL

A	NULL
total	NULL
of	NULL
5,000	NULL
cpm	NULL
(	NULL
equivalent	NULL
to	NULL
approximately	NULL
0.2	NULL
ng	NULL
)	NULL
of	NULL
a	NULL
*°P-labelled	NULL
oligonucleotide	NULL
probe	NULL
was	NULL
added	NULL
,	NULL
and	NULL
the	NULL
samples	NULL
were	NULL
incubated	NULL
for	NULL
15	NULL
min	NULL
on	NULL
ice	NULL
and	NULL
fractionated	NULL
on	NULL
5	NULL
%	NULL
native	NULL
polyacrylamide	NULL
(	NULL
PAA	NULL
)	NULL
gels	NULL
in	NULL
0.4	NULL
%	NULL
Tris-borate-EDTA	NULL
buffer	NULL
at	NULL
room	NULL
temperature	NULL
(	NULL
36	NULL
)	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
dried	NULL
and	NULL
exposed	NULL
for	NULL
autoradiography	NULL
.	NULL

The	NULL
following	NULL
oligonucleotides	NULL
were	NULL
chemically	NULL
synthesized	NULL
and	NULL
used	NULL
in	NULL
the	NULL
EMSAs	NULL
as	NULL
probes	NULL
and	NULL
competitors	NULL
:	NULL
DSE	NULL
,	NULL
(	NULL
-462	NULL
)	NULL
TTCTGAA	NULL
ACAGG	NULL
AAACC	NULL
AATAC	NULL
ACTTC	NULL
CTGTT	NULL
TAATC	NULL
AA	NULL
(	NULL
-424	NULL
)	NULL
ERE-A	NULL
,	NULL
(	NULL
-445	NULL
)	NULL
AATAC	NULL
ACTTC	NULL
CTGTT	NULL
TAATC	NULL
(	NULL
-426	NULL
)	NULL
ERE-B	NULL
,	NULL
(	NULL
-461	NULL
)	NULL
T	NULL
CTGAA	NULL
ACAGG	NULL
AAACC	NULL
AATA	NULL
(	NULL
-442	NULL
)	NULL
;	NULL
and	NULL
2xERE-A	NULL
:	NULL
A	NULL
GACTT	NULL
TGTCC	NULL
TTTGG	NULL
TATAC	NULL
ACTTC	NULL
CTGTT	NULL
AATC	NULL
(	NULL
-426	NULL
)	NULL
.	NULL

The	NULL
sequences	NULL
of	NULL
ERE	NULL
mutations	NULL
ERE-Ay	NULL
and	NULL
ERE-By	NULL
,	NULL
are	NULL
shown	NULL
above	NULL
.	NULL

In	NULL
supershift	NULL
EMSAs	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
polyclonal	NULL
antibodies	NULL
was	NULL
added	NULL
to	NULL
the	NULL
complete	NULL
binding	NULL
reaction	NULL
mixture	NULL
,	NULL
which	NULL
was	NULL
preincubated	NULL
for	NULL
25	NULL
min	NULL
on	NULL
ice	NULL
(	NULL
see	NULL
above	NULL
)	NULL
,	NULL
in	NULL
parallel	NULL
with	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
preimmune	NULL
serum	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
a	NULL
further	NULL
20-min	NULL
period	NULL
on	NULL
ice	NULL
.	NULL

In	NULL
preclearing	NULL
experiments	NULL
,	NULL
10	NULL
pg	NULL
of	NULL
nuclear	NULL
proteins	NULL
from	NULL
Jurkat	NULL
cells	NULL
was	NULL
diluted	NULL
in	NULL
50	NULL
pl	NULL
of	NULL
1	NULL
%	NULL
binding	NULL
buffer	NULL
(	NULL
36	NULL
)	NULL
and	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
2	NULL
h	NULL
with	NULL
2.5	NULL
pg	NULL
of	NULL
polyclonal	NULL
antibodies	NULL
raised	NULL
against	NULL
GABP	NULL
factors	NULL
.	NULL

A	NULL
10-ul	NULL
volume	NULL
of	NULL
protein	NULL
A	NULL
agarose	NULL
beads	NULL
(	NULL
GIBCO	NULL
)	NULL
washed	NULL
in	NULL
binding	NULL
buffer	NULL
was	NULL
added	NULL
as	NULL
a	NULL
50	NULL
%	NULL
suspension	NULL
.	NULL

The	NULL
slurry	NULL
was	NULL
incubated	NULL
at	NULL
4°C	NULL
for	NULL
3	NULL
h	NULL
with	NULL
gentle	NULL
rotation	NULL
followed	NULL
by	NULL
a	NULL
brief	NULL
centrifugation	NULL
.	NULL

The	NULL
supernatants	NULL
were	NULL
collected	NULL
and	NULL
used	NULL
in	NULL
EMSAs	NULL
.	NULL

In	NULL
EMSA-Western	NULL
blot	NULL
experiments	NULL
(	NULL
7	NULL
,	NULL
9	NULL
)	NULL
,	NULL
binding	NULL
reactions	NULL
were	NULL
scaled	NULL
up	NULL
10-fold	NULL
,	NULL
and	NULL
,	NULL
for	NULL
more	NULL
efficient	NULL
complex	NULL
formation	NULL
,	NULL
a	NULL
500-fold	NULL
molar	NULL
excess	NULL
of	NULL
unlabelled	NULL
probe	NULL
was	NULL
added	NULL
.	NULL

After	NULL
electrophoresis	NULL
on	NULL
a	NULL
preparative	NULL
5	NULL
%	NULL
native	NULL
PAA	NULL
gel	NULL
,	NULL
the	NULL
complexes	NULL
were	NULL
electrotransferred	NULL
onto	NULL
a	NULL
nitrocellulose	NULL
BA85	NULL
filter	NULL
(	NULL
first	NULL
filter	NULL
to	NULL
which	NULL
the	NULL
protein	NULL
was	NULL
bound	NULL
)	NULL
and	NULL
a	NULL
DE81	NULL
filter	NULL
paper	NULL
(	NULL
second	NULL
filter	NULL
to	NULL
which	NULL
the	NULL
released	NULL
DNA	NULL
was	NULL
bound	NULL
)	NULL
.	NULL

The	NULL
wet	NULL
DE81	NULL
filters	NULL
were	NULL
exposed	NULL
for	NULL
autoradiography	NULL
,	NULL
while	NULL
the	NULL
nitrocellulose	NULL
filters	NULL
were	NULL
processed	NULL
as	NULL
described	NULL
for	NULL
Western	NULL
blot	NULL
assays	NULL
(	NULL
35	NULL
)	NULL
.	NULL

The	NULL
ECL	NULL
system	NULL
(	NULL
Amer-sham	NULL
)	NULL
was	NULL
used	NULL
for	NULL
immunodetection	NULL
.	NULL

In	NULL
DNase	NULL
I	NULL
footprint	NULL
protection	NULL
assays	NULL
,	NULL
whole	NULL
protein	NULL
extracts	NULL
from	NULL
El4	NULL
cells	NULL
induced	NULL
for	NULL
3	NULL
h	NULL
with	NULL
tetradecanoyl	NULL
phorbol	NULL
acetate	NULL
(	NULL
TPA	NULL
)	NULL
-concanavalin	NULL
A	NULL
(	NULL
ConA	NULL
)	NULL
were	NULL
used	NULL
after	NULL
fractionation	NULL
by	NULL
heparin-agarose	NULL
column	NULL
chromatogra-phy	NULL
.	NULL

Pooled	NULL
proteins	NULL
of	NULL
0.2	NULL
and	NULL
0.4	NULL
M	NULL
KCI	NULL
fractions	NULL
were	NULL
used	NULL
in	NULL
the	NULL
assays	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
40	NULL
)	NULL
.	NULL

In	NULL
Cu®*-phenanthroline	NULL
footprint	NULL
assays	NULL
,	NULL
5'-end-la-belled	NULL
oligonucleotide	NULL
probes	NULL
were	NULL
used	NULL
.	NULL

The	NULL
assays	NULL
were	NULL
performed	NULL
in	NULL
situ	NULL
by	NULL
incubating	NULL
the	NULL
EMSA	NULL
gel	NULL
in	NULL
the	NULL
Cu®*-phenanthroline	NULL
cleavage	NULL
reagents	NULL
as	NULL
described	NULL
elsewhere	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Antibodies	NULL
.	NULL

GABPa	NULL
and	NULL
B1	NULL
proteins	NULL
were	NULL
bacterially	NULL
expressed	NULL
according	NULL
to	NULL
the	NULL
method	NULL
described	NULL
by	NULL
Thompson	NULL
et	NULL
al	NULL
.	NULL

(	NULL
45	NULL
)	NULL
,	NULL
purified	NULL
,	NULL
and	NULL
used	NULL
for	NULL
the	NULL
generation	NULL
of	NULL
polyclonal	NULL
antibodies	NULL
in	NULL
rabbits	NULL
(	NULL
10	NULL
)	NULL
.	NULL

In	NULL
Western	NULL
blots	NULL
,	NULL
incubations	NULL
of	NULL
transferred	NULL
nuclear	NULL
proteins	NULL
with	NULL
anti-GABPa	NULL
and	NULL
-81	NULL
antibodies	NULL
gave	NULL
rise	NULL
to	NULL
one	NULL
band	NULL
of	NULL
the	NULL
expected	NULL
size	NULL
(	NULL
unpublished	NULL
results	NULL
)	NULL
.	NULL

Antibodies	NULL
raised	NULL
against	NULL
Ets-1	NULL
and	NULL
Ets-2	NULL
(	NULL
sc-112	NULL
)	NULL
,	NULL
PEA3	NULL
(	NULL
se-113	NULL
)	NULL
,	NULL
Erk-1	NULL
(	NULL
se-93	NULL
)	NULL
,	NULL
Erk-2	NULL
(	NULL
se-154	NULL
)	NULL
,	NULL
and	NULL
JNK1	NULL
(	NULL
sc-474	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
Antibodies	NULL
directed	NULL
against	NULL
recombinant	NULL
Elk-1	NULL
,	NULL
Elf-1	NULL
,	NULL
and	NULL
NFATp	NULL
were	NULL
kind	NULL
gifts	NULL
of	NULL
A.	NULL
Nordheim	NULL
,	NULL
J.	NULL
Leiden	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
,	NULL
respectively	NULL
.	NULL

RESULTS	NULL
The	NULL
activity	NULL
of	NULL
a	NULL
distal	NULL
IL-2	NULL
enhancer	NULL
is	NULL
controlled	NULL
through	NULL
binding	NULL
sites	NULL
for	NULL
Ets-like	NULL
transcription	NULL
factors	NULL
.	NULL

Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
IL-2-tkCAT	NULL
reporter	NULL
constructs	NULL
bearing	NULL
various	NULL
DNA	NULL
segments	NULL
from	NULL
the	NULL
conserved	NULL
5	NULL
'	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
.	NULL

As	NULL
it	NULL
can	NULL
be	NULL
seen	NULL
in	NULL
Fig	NULL
.	NULL

1	NULL
,	NULL
a	NULL
segment	NULL
spanning	NULL
the	NULL
upstream	NULL
nucleotides	NULL
from	NULL
positions	NULL
-499	NULL
to	NULL
+5	NULL
(	NULL
-499/+5	NULL
)	NULL
showed	NULL
approximately	NULL
50	NULL
%	NULL
more	NULL
inducible	NULL
activity	NULL
than	NULL
the	NULL
proximal	NULL
-326/+5	NULL
segment	NULL
which	NULL
is	NULL
thought	NULL
to	NULL
har-	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
GABP	NULL
FACTORS	NULL
CONTROL	NULL
A	NULL
DISTAL	NULL
IL-2	NULL
ENHANCER	NULL
4383	NULL
A	NULL
)	NULL
%	NULL
homology	NULL
,	NULL
human/mouse	NULL
CAT-activity	NULL
,	NULL
fold	NULL
over	NULL
vector	NULL
[	NULL
]	NULL
c1o18-969	NULL
)	NULL
2	NULL
10	NULL
]	NULL
(	NULL
52441326	NULL
)	NULL
[	NULL
_-	NULL
om14524	NULL
)	NULL
~~	NULL
[	NULL
_	NULL
]	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

A	NULL
transcriptional	NULL
enhancer	NULL
is	NULL
located	NULL
within	NULL
the	NULL
-502/-413	NULL
DNA	NULL
segment	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
upstream	NULL
sequences	NULL
of	NULL
human	NULL
and	NULL
murine	NULL
IL-2	NULL
genes	NULL
are	NULL
highly	NULL
conserved	NULL
.	NULL

The	NULL
scheme	NULL
shows	NULL
the	NULL
sequence	NULL
homologies	NULL
between	NULL
the	NULL
human	NULL
and	NULL
murine	NULL
IL-2	NULL
genes	NULL
(	NULL
15	NULL
,	NULL
25	NULL
)	NULL
as	NULL
percentages	NULL
of	NULL
homology	NULL
in	NULL
a	NULL
window	NULL
of	NULL
10	NULL
nucleotides	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Activities	NULL
of	NULL
various	NULL
DNA	NULL
segments	NULL
from	NULL
the	NULL
5	NULL
'	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
after	NULL
transfection	NULL
into	NULL
Jurkat	NULL
cells	NULL
.	NULL

CAT	NULL
constructs	NULL
containing	NULL
the	NULL
indicated	NULL
DNA	NULL
segments	NULL
in	NULL
front	NULL
of	NULL
the	NULL
tk	NULL
promoter	NULL
in	NULL
pBLCATS5	NULL
(	NULL
2	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
.	NULL

At	NULL
20	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
divided	NULL
.	NULL

One-half	NULL
of	NULL
the	NULL
cells	NULL
was	NULL
used	NULL
as	NULL
an	NULL
uninduced	NULL
control	NULL
(	NULL
W/O	NULL
)	NULL
;	NULL
the	NULL
other	NULL
half	NULL
was	NULL
induced	NULL
by	NULL
TPA	NULL
(	NULL
20	NULL
ng/m	NULL
!	NULL
)	NULL

and	NULL
ionomycin	NULL
(	NULL
0.5	NULL
M	NULL
)	NULL
(	NULL
T+1	NULL
)	NULL
for	NULL
20	NULL
h.	NULL
bor	NULL
the	NULL
majority	NULL
of	NULL
IL-2	NULL
promoter-enhancer	NULL
DNA	NULL
sequences	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
fragment	NULL
-583/-164	NULL
,	NULL
which	NULL
contains	NULL
more	NULL
upstream	NULL
DNA	NULL
but	NULL
lacks	NULL
the	NULL
immediate	NULL
proximal	NULL
DNA	NULL
,	NULL
was	NULL
even	NULL
stronger	NULL
than	NULL
the	NULL
former	NULL
DNA	NULL
fragments	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
DNA	NULL
motifs	NULL
responsible	NULL
for	NULL
this	NULL
increase	NULL
in	NULL
activity	NULL
,	NULL
we	NULL
used	NULL
fragments	NULL
-583/-326	NULL
and	NULL
-502/-413	NULL
in	NULL
transfections	NULL
.	NULL

Since	NULL
transfection	NULL
of	NULL
the	NULL
-502/-413	NULL
fragment	NULL
resulted	NULL
in	NULL
approximately	NULL
the	NULL
same	NULL
,	NULL
albeit	NULL
less-inducible	NULL
,	NULL
activity	NULL
as	NULL
that	NULL
with	NULL
the	NULL
former	NULL
longer	NULL
fragment	NULL
,	NULL
we	NULL
focused	NULL
our	NULL
attention	NULL
on	NULL
this	NULL
fragment	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
the	NULL
-502/-413	NULL
DNA	NULL
segment	NULL
was	NULL
stronger	NULL
than	NULL
the	NULL
activity	NULL
of	NULL
most	NULL
of	NULL
the	NULL
other	NULL
DNA	NULL
segments	NULL
from	NULL
the	NULL
conserved	NULL
region	NULL
upstream	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

In	NULL
two	NULL
copies	NULL
,	NULL
the	NULL
inducible	NULL
activity	NULL
of	NULL
the	NULL
-502/-413	NULL
segment	NULL
was	NULL
almost	NULL
as	NULL
strong	NULL
as	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
spanning	NULL
about	NULL
100	NULL
bp	NULL
more	NULL
DNA	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

However	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
induction	NULL
of	NULL
the	NULL
proximal	NULL
IL-2	NULL
promoter	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
which	NULL
requires	NULL
treatment	NULL
of	NULL
cells	NULL
with	NULL
TPA	NULL
and	NULL
ionomycin	NULL
,	NULL
TPA	NULL
treatment	NULL
alone	NULL
induced	NULL
the	NULL
full	NULL
activity	NULL
of	NULL
the	NULL
-502/	NULL
-413	NULL
segment	NULL
.	NULL

TPA	NULL
and	NULL
ionomycin	NULL
treatment	NULL
led	NULL
only	NULL
to	NULL
a	NULL
slight	NULL
increase	NULL
of	NULL
induction	NULL
,	NULL
while	NULL
similarly	NULL
to	NULL
the	NULL
promoter	NULL
induction	NULL
,	NULL
ConA	NULL
,	NULL
ionomycin	NULL
,	NULL
or	NULL
forskolin	NULL
treatment	NULL
alone	NULL
were	NULL
without	NULL
any	NULL
stimulatory	NULL
effect	NULL
on	NULL
this	NULL
distal	NULL
element	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

Since	NULL
the	NULL
-502/-413	NULL
element	NULL
was	NULL
also	NULL
active	NULL
from	NULL
a	NULL
position	NULL
downstream	NULL
of	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

2B	NULL
)	NULL
,	NULL
it	NULL
is	NULL
able	NULL
to	NULL
act	NULL
as	NULL
a	NULL
transcriptional	NULL
enhancer	NULL
,	NULL
and	NULL
,	NULL
for	NULL
simplicity	NULL
,	NULL
we	NULL
designate	NULL
it	NULL
the	NULL
distal	NULL
IL-2	NULL
enhancer	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
proximal	NULL
IL-2	NULL
promoter	NULL
.	NULL

Induction	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
by	NULL
TPA	NULL
plus	NULL
ionomycin	NULL
is	NULL
efficiently	NULL
suppressed	NULL
by	NULL
100-ng/ml	NULL
CsA	NULL
and	NULL
impaired	NULL
by	NULL
forskolin	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Both	NULL
compounds	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
distal	NULL
enhancer	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
)	NULL
.	NULL

This	NULL
shows	NULL
that	NULL
the	NULL
distal	NULL
enhancer	NULL
differs	NULL
distinctly	NULL
in	NULL
its	NULL
induction	NULL
properties	NULL
from	NULL
the	NULL
proximal	NULL
promoter	NULL
.	NULL

The	NULL
distal	NULL
enhancer	NULL
contains	NULL
potential	NULL
binding	NULL
sites	NULL
for	NULL
oc-	NULL
tamer	NULL
factors	NULL
around	NULL
position	NULL
-495	NULL
,	NULL
GATA	NULL
factors	NULL
at	NULL
-480	NULL
,	NULL
and	NULL
two	NULL
sites	NULL
for	NULL
the	NULL
binding	NULL
of	NULL
Ets-like	NULL
factors	NULL
,	NULL
which	NULL
were	NULL
designated	NULL
EREs	NULL
,	NULL
at	NULL
-450	NULL
and	NULL
-435	NULL
(	NULL
Fig	NULL
.	NULL

3C	NULL
)	NULL
.	NULL

The	NULL
EREs	NULL
form	NULL
a	NULL
DSE	NULL
.	NULL

In	NULL
DNase	NULL
I	NULL
footprint	NULL
experiments	NULL
with	NULL
whole	NULL
cellular	NULL
protein	NULL
extracts	NULL
enriched	NULL
by	NULL
heparin-agarose	NULL
chroma-tography	NULL
,	NULL
these	NULL
motifs	NULL
were	NULL
protected	NULL
by	NULL
DNA-binding	NULL
proteins	NULL
from	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

Introduction	NULL
of	NULL
point	NULL
mutations	NULL
into	NULL
the	NULL
ERE	NULL
sites	NULL
suppressing	NULL
factor	NULL
binding	NULL
had	NULL
a	NULL
suppressive	NULL
effect	NULL
on	NULL
enhancer	NULL
induction	NULL
.	NULL

A	NULL
moderate	NULL
suppression	NULL
was	NULL
observed	NULL
when	NULL
point	NULL
mutations	NULL
were	NULL
introduced	NULL
into	NULL
the	NULL
GATA	NULL
site	NULL
,	NULL
while	NULL
mutation	NULL
of	NULL
the	NULL
octamer	NULL
site	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
a	NULL
suppression	NULL
of	NULL
enhancer	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
)	NULL
.	NULL

This	NULL
shows	NULL
that	NULL
the	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
binding	NULL
to	NULL
the	NULL
EREs	NULL
is	NULL
important	NULL
for	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
entire	NULL
distal	NULL
enhancer	NULL
.	NULL

The	NULL
palindromic	NULL
configuration	NULL
of	NULL
EREs	NULL
is	NULL
very	NULL
important	NULL
for	NULL
the	NULL
full	NULL
activity	NULL
of	NULL
the	NULL
distal	NULL
enhancer	NULL
.	NULL

Multimers	NULL
of	NULL
DSE	NULL
containing	NULL
the	NULL
EREs	NULL
in	NULL
the	NULL
natural	NULL
palindromic	NULL
configuration	NULL
showed	NULL
a	NULL
strong	NULL
induction	NULL
in	NULL
Jurkat	NULL
cells	NULL
,	NULL
while	NULL
multimeric	NULL
EREs	NULL
carrying	NULL
direct	NULL
ERE	NULL
repeats	NULL
were	NULL
only	NULL
poorly	NULL
active	NULL
.	NULL

Mutations	NULL
of	NULL
GG	NULL
nucleotides	NULL
within	NULL
the	NULL
GGAA	NULL
core	NULL
in	NULL
one	NULL
of	NULL
both	NULL
EREs	NULL
had	NULL
a	NULL
deleterious	NULL
effect	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
tkCAT	NULL
reporter	NULL
genes	NULL
under	NULL
the	NULL
control	NULL
of	NULL
DSE	NULL
multimers	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

Mutations	NULL
within	NULL
one	NULL
ERE	NULL
motif	NULL
(	NULL
ERE-Am	NULL
)	NULL
exerted	NULL
a	NULL
moderate	NULL
negative	NULL
effect	NULL
on	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter-enhancer	NULL
region	NULL
.	NULL

This	NULL
is	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
in	NULL
which	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
wild-type	NULL
promoter	NULL
spanning	NULL
nucleotides	NULL
from	NULL
-583	NULL
to	NULL
+5	NULL
is	NULL
compared	NULL
with	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
same	NULL
promoter	NULL
but	NULL
mutated	NULL
in	NULL
the	NULL
ERE-A	NULL
motif	NULL
.	NULL

The	NULL
IL-2	NULL
promoter	NULL
containing	NULL
a	NULL
mutated	NULL
ERE	NULL
motif	NULL
(	NULL
ERE-Ay	NULL
,	NULL
)	NULL
shows	NULL
approximately	NULL
75	NULL
%	NULL
of	NULL
the	NULL
constitutive	NULL
and	NULL
inducible	NULL
activity	NULL
of	NULL
the	NULL
wild-type	NULL
promoter	NULL
.	NULL

This	NULL
indicates	NULL
that	NULL
the	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
ERE	NULL
motifs	NULL
contribute	NULL
to	NULL
the	NULL
overall	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
EREs	NULL
of	NULL
the	NULL
distal	NULL
enhancer	NULL
are	NULL
bound	NULL
by	NULL
the	NULL
transcription	NULL
factors	NULL
GABPa	NULL
and	NULL
GABPRB	NULL
.	NULL

Incubation	NULL
of	NULL
the	NULL
DSE	NULL
4384	NULL
AVOTS	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

10	NULL
B	NULL
)	NULL
30	NULL
[	NULL
]	NULL
326/+5	NULL
A	NULL
2x	NULL
(	NULL
-502/-413	NULL
)	NULL
-499/+5	NULL
&	NULL
C	NULL
5°	NULL
E	NULL
3	NULL
3	NULL
3	NULL
E	NULL
5	NULL
€	NULL
&	NULL
3	NULL
20	NULL
3	NULL
6	NULL
]	NULL
3	NULL
&	NULL
m	NULL
a	NULL
101	NULL
bss	NULL
sy	NULL
boss	NULL
ss	NULL
sss	NULL
7	NULL
B	NULL
(	NULL
%	NULL
4	NULL
2	NULL
0	NULL
T	NULL
ConA	NULL
T+ConA	NULL
|	NULL
T+L	NULL
-	NULL
TeleCsA	NULL
T+LF	NULL
|	NULL
OF	NULL
céxfé	NULL
‘	NULL
ob	NULL
~§¢	NULL
%	NULL
’	NULL
V	NULL
‘	NULL
§	NULL
yh	NULL
hs	NULL
a	NULL
&	NULL
*	NULL
3°	NULL
«	NULL
*	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Induction	NULL
properties	NULL
of	NULL
the	NULL
distal	NULL
IL-2	NULL
enhancer	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
distal	NULL
IL-2	NULL
enhancer	NULL
differs	NULL
in	NULL
its	NULL
induction	NULL
properties	NULL
from	NULL
the	NULL
proximal	NULL
IL-2	NULL
promoter	NULL
.	NULL

Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
CAT	NULL
constructs	NULL
containing	NULL
either	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
(	NULL
-326/+5	NULL
)	NULL
,	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
distal	NULL
enhancer	NULL
(	NULL
-502/-413	NULL
,	NULL
cloned	NULL
in	NULL
the	NULL
Xbal	NULL
site	NULL
of	NULL
pBLCATS	NULL
[	NULL
2a	NULL
]	NULL
in	NULL
the	NULL
orientation	NULL
of	NULL
transcription	NULL
)	NULL
,	NULL
or	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
-499/+5	NULL
DNA	NULL
fragment	NULL
containing	NULL
the	NULL
proximal	NULL
and	NULL
distal	NULL
promoters-enhancers	NULL
.	NULL

At	NULL
20	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
TPA	NULL
(	NULL
T	NULL
)	NULL
(	NULL
20	NULL
ng/ml	NULL
)	NULL
,	NULL
ConA	NULL
(	NULL
5	NULL
pg/ml	NULL
)	NULL
,	NULL
ionomycin	NULL
(	NULL
I	NULL
)	NULL
(	NULL
0.5	NULL
wM	NULL
)	NULL
,	NULL
forskolin	NULL
(	NULL
F	NULL
)	NULL
(	NULL
5	NULL
mM	NULL
)	NULL
,	NULL
CsA	NULL
(	NULL
200	NULL
ng/ml	NULL
)	NULL
,	NULL
or	NULL
combinations	NULL
of	NULL
these	NULL
compounds	NULL
as	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
distal	NULL
(	NULL
dist	NULL
)	NULL
IL-2	NULL
enhancer	NULL
acts	NULL
downstream	NULL
from	NULL
the	NULL
CAT	NULL
reporter	NULL
gene	NULL
.	NULL

A	NULL
tkCAT	NULL
construct	NULL
containing	NULL
two	NULL
copies	NULL
of	NULL
distal	NULL
enhancer	NULL
(	NULL
cloned	NULL
into	NULL
the	NULL
Smal	NULL
site	NULL
of	NULL
pBLCATS	NULL
behind	NULL
the	NULL
CAT	NULL
gene	NULL
)	NULL
was	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
which	NULL
were	NULL
induced	NULL
with	NULL
TPA-ionomycin	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Point	NULL
mutations	NULL
within	NULL
the	NULL
Ets-like	NULL
ERE-A	NULL
motif	NULL
of	NULL
the	NULL
distal	NULL
enhancer	NULL
interfere	NULL
with	NULL
the	NULL
activation	NULL
of	NULL
enhancer	NULL
activity	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

CAT	NULL
constructs	NULL
containing	NULL
two	NULL
copies	NULL
of	NULL
wild-type	NULL
enhancer	NULL
(	NULL
WT	NULL
)	NULL
or	NULL
of	NULL
enhancers	NULL
with	NULL
mutations	NULL
within	NULL
the	NULL
octamer	NULL
site	NULL
(	NULL
Oct	NULL
,	NULL
,	NULL
,	NULL
)	NULL
,	NULL
the	NULL
GATA	NULL
site	NULL
(	NULL
GATA	NULL
,	NULL
,	NULL
,	NULL
)	NULL
,	NULL
or	NULL
the	NULL
ERE-A	NULL
motif	NULL
(	NULL
ERE-A	NULL
,	NULL
,	NULL
,	NULL
)	NULL
,	NULL
were	NULL
transfected	NULL
in	NULL
parallel	NULL
into	NULL
Jurkat	NULL
cells	NULL
which	NULL
were	NULL
induced	NULL
by	NULL
TPA-ionomycin	NULL
for	NULL
20	NULL
h.	NULL
with	NULL
nuclear	NULL
proteins	NULL
from	NULL
uninduced	NULL
or	NULL
induced	NULL
Jurkat	NULL
cells	NULL
plex	NULL
formation	NULL
[	NULL
see	NULL
lanes	NULL
7	NULL
to	NULL
10	NULL
]	NULL
)	NULL
.	NULL

Complexes	NULL
II	NULL
,	NULL
III	NULL
,	NULL
and	NULL
IV	NULL
generated	NULL
four	NULL
large	NULL
,	NULL
prominent	NULL
complexes	NULL
in	NULL
EMSAs	NULL
,	NULL
which	NULL
were	NULL
also	NULL
generated	NULL
with	NULL
single	NULL
EREs	NULL
,	NULL
while	NULL
complex	NULL
I	NULL
was	NULL
were	NULL
designated	NULL
complexes	NULL
I	NULL
,	NULL
II	NULL
,	NULL
III	NULL
,	NULL
and	NULL
IV	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
;	NULL
a	NULL
further	NULL
specific	NULL
for	NULL
the	NULL
DSE	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

The	NULL
generation	NULL
of	NULL
complex	NULL
prominent	NULL
,	NULL
faster	NULL
running	NULL
complex	NULL
is	NULL
due	NULL
to	NULL
unspecific	NULL
com-	NULL
I	NULL
depends	NULL
on	NULL
the	NULL
palindromic	NULL
configuration	NULL
of	NULL
EREs	NULL
within	NULL
the	NULL
A	NULL
)	NULL
BSA	NULL
-	NULL
El4+	NULL
B	NULL
)	NULL
BSA	NULL
_-	NULL
El4+	NULL
Pu12	NULL
”	NULL
7345	NULL
Pu	NULL
1	NULL
2	NULL
34	NULL
5	NULL
-450	NULL
>	NULL
433°	NULL
470+	NULL
*	NULL
*	NULL
f	NULL
-420	NULL
*	NULL
~478	NULL
>	NULL
sar	NULL
-se	NULL
so	NULL
so	NULL
an	NULL
aso	NULL
e	NULL
sof	NULL
(	NULL
5	NULL
)	NULL
TATGCAATTAGCTCATTGTGTGGATAAAAAGGTAAAACCATTC	NULL
e	NULL
(	NULL
3	NULL
'	NULL
)	NULL
ATACGTTAATCGAGTAACACACCTATTTTTCCATTTTGGTAAG	NULL
``	NULL
L_	NULL
]	NULL
noma	NULL
]	NULL
fortes	NULL
c	NULL
Oct	NULL
GATA	NULL
F	NULL
a_	NULL
``	NULL
e	NULL
>	NULL
FREA	NULL
-450	NULL
£200	NULL
-417	NULL
g	NULL
«	NULL
C	NULL
raped	NULL
=	NULL
--	NULL
-	NULL
~500	NULL
»	NULL
``	NULL
TGAAACAGGAAACCAATACACTTCCTGTTTAATCAACAAATCT	NULL
(	NULL
3	NULL
)	NULL
ACTTTGTCCTTTGGTTATGTGAAGGACAAATTAGTTGTTTAGA	NULL
(	NULL
5	NULL
)	NULL
me*	NULL
'-	NULL
TREB	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Detection	NULL
of	NULL
factor	NULL
binding	NULL
to	NULL
the	NULL
Oct	NULL
,	NULL
GATA	NULL
,	NULL
and	NULL
Ets-like	NULL
ERE	NULL
motifs	NULL
in	NULL
DNase	NULL
I	NULL
footprint	NULL
protection	NULL
assays	NULL
.	NULL

DNA	NULL
fragments	NULL
(	NULL
-583	NULL
to	NULL
-326	NULL
)	NULL
containing	NULL
the	NULL
distal	NULL
enhancer	NULL
were	NULL
labelled	NULL
at	NULL
either	NULL
position	NULL
-326	NULL
(	NULL
A	NULL
)	NULL
or	NULL
position	NULL
-583	NULL
(	NULL
B	NULL
)	NULL
and	NULL
incubated	NULL
with	NULL
25	NULL
,	NULL
50	NULL
,	NULL
or	NULL
100	NULL
pg	NULL
(	NULL
lanes	NULL
3	NULL
to	NULL
5	NULL
)	NULL
of	NULL
protein	NULL
extracts	NULL
from	NULL
TPA-induced	NULL
El4	NULL
cells	NULL
fractionated	NULL
on	NULL
a	NULL
heparin-agarose	NULL
column	NULL
.	NULL

In	NULL
the	NULL
control	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
,	NULL
the	NULL
probe	NULL
was	NULL
incubated	NULL
with	NULL
25	NULL
and	NULL
50	NULL
g	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
(	NULL
BSA	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
DNase	NULL
I	NULL
cleavage	NULL
.	NULL

Pu	NULL
,	NULL
purine-specific	NULL
sequencing	NULL
reactions	NULL
.	NULL

Only	NULL
parts	NULL
of	NULL
footprinting	NULL
gels	NULL
with	NULL
the	NULL
relevant	NULL
factor	NULL
binding	NULL
sites	NULL
are	NULL
shown	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Sequence	NULL
of	NULL
the	NULL
distal	NULL
IL-2	NULL
enhancer	NULL
.	NULL

The	NULL
brackets	NULL
indicate	NULL
the	NULL
footprints	NULL
as	NULL
detected	NULL
over	NULL
the	NULL
factor	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
DNase	NULL
I	NULL
footprint	NULL
protection	NULL
assays	NULL
.	NULL

Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
GABP	NULL
FACTORS	NULL
CONTROL	NULL
A	NULL
DISTAL	NULL
IL-2	NULL
ENHANCER	NULL
-	NULL
4385	NULL
A	NULL
)	NULL
30	NULL
_	NULL
]	NULL
a	NULL
T+I+F	NULL
bo	NULL
&	NULL
a	NULL
pea	NULL
&	NULL
a	NULL
(	NULL
uonepfare	NULL
4	NULL
)	NULL
W	NULL
a*	NULL
ee	NULL
&	NULL
C_s	NULL
&	NULL
F	NULL
¥	NULL
__	NULL
g	NULL
V	NULL
Na	NULL
!	NULL

bo	NULL
tn	NULL
j	NULL
U	NULL
w/o	NULL
S	NULL
T+I	NULL
--	NULL
I	NULL
20	NULL
157	NULL
107	NULL
4	NULL
)	NULL
$	NULL
90	NULL
$	NULL
wT	NULL
ERE-Am-s	NULL
&	NULL
(	NULL
583/45	NULL
)	NULL
-	NULL
(	NULL
5838	NULL
)	NULL
w	NULL
496	NULL
tr	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

The	NULL
DSE-ERE	NULL
motifs	NULL
act	NULL
as	NULL
transcriptional	NULL
enhancers	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
DSE	NULL
displays	NULL
a	NULL
strong	NULL
inducible	NULL
activity	NULL
in	NULL
Jurkat	NULL
cells	NULL
.	NULL

The	NULL
CAT	NULL
constructs	NULL
containing	NULL
multiple	NULL
copies	NULL
of	NULL
DSE	NULL
and	NULL
ERE	NULL
motifs	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
were	NULL
transfected	NULL
in	NULL
parallel	NULL
into	NULL
Jurkat	NULL
cells	NULL
which	NULL
were	NULL
induced	NULL
by	NULL
TPA-ionomycin	NULL
(	NULL
T+1	NULL
)	NULL
or	NULL
additionally	NULL
by	NULL
forskolin	NULL
(	NULL
T+I+F	NULL
)	NULL
for	NULL
20	NULL
h.	NULL
(	NULL
B	NULL
)	NULL
The	NULL
ERE-A	NULL
site	NULL
from	NULL
the	NULL
distal	NULL
IL-2	NULL
enhancer	NULL
contributes	NULL
to	NULL
the	NULL
overall	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
5	NULL
'	NULL
region	NULL
.	NULL

CAT	NULL
constructs	NULL
bearing	NULL
either	NULL
the	NULL
5	NULL
'	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
region	NULL
(	NULL
-583/+5	NULL
)	NULL
or	NULL
the	NULL
same	NULL
region	NULL
but	NULL
containing	NULL
a	NULL
defective	NULL
ERE-A	NULL
site	NULL
(	NULL
ERE-Am	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
Jurkat	NULL
cells	NULL
which	NULL
were	NULL
induced	NULL
with	NULL
TPA-ionomycin	NULL
for	NULL
20	NULL
h.	NULL
W/O	NULL
,	NULL
without	NULL
induction	NULL
.	NULL

DSE	NULL
.	NULL

When	NULL
two	NULL
EREs	NULL
were	NULL
fused	NULL
to	NULL
a	NULL
tandem	NULL
repeat	NULL
,	NULL
no	NULL
complex	NULL
I	NULL
was	NULL
generated	NULL
,	NULL
although	NULL
the	NULL
tandem	NULL
repeat	NULL
was	NULL
of	NULL
the	NULL
size	NULL
of	NULL
the	NULL
palindromic	NULL
DSE	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Competitions	NULL
with	NULL
an	NULL
excess	NULL
of	NULL
unlabelled	NULL
ERE-A	NULL
or	NULL
ERE-B	NULL
oligonucleotide	NULL
suppressed	NULL
the	NULL
generation	NULL
of	NULL
complexes	NULL
I	NULL
to	NULL
IV	NULL
,	NULL
while	NULL
competitions	NULL
with	NULL
EREs	NULL
mutated	NULL
in	NULL
the	NULL
two	NULL
central	NULL
G	NULL
residues	NULL
did	NULL
not	NULL
affect	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
and	NULL
6A	NULL
)	NULL
.	NULL

Competitions	NULL
with	NULL
AP-1	NULL
(	NULL
TRE	NULL
and	NULL
UPS	NULL
)	NULL
,	NULL
octamer	NULL
(	NULL
Oct	NULL
and	NULL
UPS	NULL
)	NULL
,	NULL
Ets	NULL
(	NULL
NF-	NULL
«	NULL
4	NULL
)	NULL
,	NULL
and	NULL
NF-AT	NULL
sites	NULL
were	NULL
also	NULL
without	NULL
effect	NULL
on	NULL
complex	NULL
formation	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
,	NULL
lanes	NULL
6	NULL
to	NULL
12	NULL
)	NULL
.	NULL

The	NULL
inability	NULL
of	NULL
Ets-NF-	NULL
«	NULL
4	NULL
and	NULL
NF-AT-Pu-b	NULL
,	NULL
oligonucleotides	NULL
to	NULL
compete	NULL
for	NULL
the	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
ERE	NULL
or	NULL
DSE	NULL
DNA	NULL
suggests	NULL
that	NULL
neither	NULL
typical	NULL
Ets	NULL
proteins	NULL
,	NULL
such	NULL
as	NULL
Ets-1	NULL
or	NULL
Ets-2	NULL
,	NULL
nor	NULL
NF-AT	NULL
proteins	NULL
are	NULL
components	NULL
of	NULL
ERE	NULL
complexes	NULL
.	NULL

Typical	NULL
ERE	NULL
complexes	NULL
were	NULL
also	NULL
generated	NULL
in	NULL
EMSAs	NULL
by	NULL
using	NULL
nuclear	NULL
proteins	NULL
from	NULL
several	NULL
other	NULL
T-cell	NULL
lines	NULL
,	NULL
such	NULL
as	NULL
A	NULL
3.01	NULL
,	NULL
HUT	NULL
78	NULL
,	NULL
and	NULL
El4	NULL
T	NULL
lymphoma	NULL
cells	NULL
,	NULL
and	NULL
human	NULL
peripheral	NULL
T	NULL
lymphocytes	NULL
.	NULL

One	NULL
notable	NULL
exception	NULL
was	NULL
Molt	NULL
4	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
contain	NULL
very	NULL
low	NULL
levels	NULL
of	NULL
complex	NULL
I	NULL
to	NULL
IV	NULL
proteins	NULL
but	NULL
rather	NULL
Pu.1-SpiB-like	NULL
proteins	NULL
,	NULL
which	NULL
bind	NULL
to	NULL
the	NULL
ERE	NULL
motifs	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
cleavage	NULL
patterns	NULL
of	NULL
DSE	NULL
and	NULL
ERE	NULL
complexes	NULL
in	NULL
Cu	NULL
``	NULL
*-phenanthroline	NULL
footprint	NULL
assays	NULL
indicate	NULL
a	NULL
tight	NULL
binding	NULL
of	NULL
complex	NULL
II	NULL
to	NULL
IV	NULL
proteins	NULL
to	NULL
five	NULL
(	NULL
or	NULL
six	NULL
)	NULL
nucleotides	NULL
around	NULL
the	NULL
GGAA	NULL
core	NULL
.	NULL

For	NULL
the	NULL
complex	NULL
I	NULL
proteins	NULL
,	NULL
more	NULL
nucleotides	NULL
were	NULL
found	NULL
to	NULL
be	NULL
contacted	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
additional	NULL
proteins	NULL
are	NULL
components	NULL
of	NULL
large	NULL
complex	NULL
I	NULL
.	NULL

To	NULL
determine	NULL
which	NULL
transcription	NULL
factors	NULL
are	NULL
part	NULL
of	NULL
ERE	NULL
complexes	NULL
,	NULL
a	NULL
panel	NULL
of	NULL
antibodies	NULL
raised	NULL
against	NULL
Ets-like	NULL
and	NULL
NF-AT	NULL
factors	NULL
was	NULL
used	NULL
in	NULL
supershift	NULL
EMSAs	NULL
.	NULL

Neither	NULL
antibodies	NULL
raised	NULL
against	NULL
Ets-1	NULL
or	NULL
Ets-2	NULL
or	NULL
Elk	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
nor	NULL
against	NULL
Elf-1	NULL
,	NULL
PEA3	NULL
,	NULL
or	NULL
NF-ATp	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
reacted	NULL
with	NULL
the	NULL
ERE	NULL
complexes	NULL
.	NULL

However	NULL
,	NULL
antibodies	NULL
raised	NULL
against	NULL
the	NULL
GABPa	NULL
and	NULL
-B	NULL
specifically	NULL
suppressed	NULL
the	NULL
generation	NULL
of	NULL
complexes	NULL
II	NULL
to	NULL
IV	NULL
when	NULL
they	NULL
were	NULL
added	NULL
to	NULL
EMSAs	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
or	NULL
in	NULL
preclearing	NULL
assays	NULL
(	NULL
Fig	NULL
.	NULL

6C	NULL
)	NULL
.	NULL

In	NULL
EMSA-Western	NULL
blot	NULL
assays	NULL
,	NULL
anti-GABPa	NULL
antibodies	NULL
reacted	NULL
with	NULL
almost	NULL
all	NULL
ERE	NULL
complexes	NULL
,	NULL
including	NULL
the	NULL
huge	NULL
complex	NULL
I	NULL
and	NULL
complex	NULL
VI	NULL
,	NULL
a	NULL
fast-migrating	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
and	NULL
11	NULL
to	NULL
14	NULL
)	NULL
.	NULL

GABP	NULL
$	NULL
B	NULL
antibodies	NULL
reacted	NULL
preferentially	NULL
with	NULL
complexes	NULL
I	NULL
and	NULL
III	NULL
(	NULL
Fig	NULL
.	NULL

6D	NULL
)	NULL
.	NULL

These	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
GABP	NULL
factors	NULL
are	NULL
the	NULL
most	NULL
prominent	NULL
proteins	NULL
binding	NULL
to	NULL
the	NULL
ERE-DSE	NULL
motifs	NULL
.	NULL

c-Raf	NULL
enhances	NULL
IL-2	NULL
induction	NULL
through	NULL
GABP	NULL
factors	NULL
.	NULL

Cotransfections	NULL
of	NULL
CAT	NULL
reporter	NULL
genes	NULL
controlled	NULL
by	NULL
multiples	NULL
of	NULL
the	NULL
DSE	NULL
or	NULL
distal	NULL
enhancer	NULL
with	NULL
GABPa	NULL
and	NULL
-B	NULL
expression	NULL
vectors	NULL
into	NULL
Jurkat	NULL
cells	NULL
and	NULL
A	NULL
3.01	NULL
T	NULL
cells	NULL
resulted	NULL
in	NULL
a	NULL
distinct	NULL
increase	NULL
in	NULL
CAT	NULL
activities	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
a	NULL
5-fold	NULL
increase	NULL
was	NULL
detected	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
DSE	NULL
,	NULL
and	NULL
a	NULL
2.2-fold	NULL
increase	NULL
was	NULL
detected	NULL
for	NULL
distal	NULL
enhancer	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Mutations	NULL
within	NULL
one	NULL
of	NULL
both	NULL
ERE	NULL
motifs	NULL
abolished	NULL
any	NULL
induction	NULL
,	NULL
indicating	NULL
the	NULL
important	NULL
functional	NULL
role	NULL
of	NULL
GABP	NULL
binding	NULL
for	NULL
induction	NULL
of	NULL
the	NULL
distal	NULL
enhancer	NULL
.	NULL

When	NULL
in	NULL
the	NULL
same	NULL
cells	NULL
the	NULL
effect	NULL
of	NULL
GABPs	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
entire	NULL
IL-2	NULL
promoter-enhancer	NULL
region	NULL
was	NULL
investigated	NULL
,	NULL
a	NULL
weak	NULL
(	NULL
1.5-	NULL
to	NULL
2-fold	NULL
)	NULL
increase	NULL
in	NULL
induction	NULL
was	NULL
observed	NULL
.	NULL

However	NULL
,	NULL
this	NULL
effect	NULL
could	NULL
be	NULL
enhanced	NULL
2-fold	NULL
by	NULL
cotranfection	NULL
of	NULL
a	NULL
vector	NULL
overexpressing	NULL
BXB	NULL
,	NULL
a	NULL
constitutive-active	NULL
version	NULL
of	NULL
c-Raf	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

Mutation	NULL
of	NULL
one	NULL
GABP	NULL
binding	NULL
site	NULL
abolished	NULL
GABP-mediated	NULL
increase	NULL
of	NULL
IL-2	NULL
promoter-enhancer	NULL
activity	NULL
and	NULL
impaired	NULL
the	NULL
stimulatory	NULL
effect	NULL
of	NULL
Raf-BXB	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

These	NULL
data	NULL
indicate	NULL
that	NULL
the	NULL
c-Raf-mediated	NULL
increase	NULL
of	NULL
IL-2	NULL
induction	NULL
is	NULL
partially	NULL
mediated	NULL
through	NULL
the	NULL
GABP	NULL
factors	NULL
binding	NULL
to	NULL
the	NULL
distal	NULL
IL-2	NULL
enhancer	NULL
.	NULL

To	NULL
substantiate	NULL
the	NULL
observed	NULL
effect	NULL
of	NULL
c-Raf	NULL
on	NULL
GABP-mediated	NULL
enhancer	NULL
activity	NULL
,	NULL
we	NULL
cotransfected	NULL
the	NULL
4xDSE-tkCAT	NULL
construct	NULL
into	NULL
Jurkat	NULL
cells	NULL
with	NULL
several	NULL
cDNA	NULL
vectors	NULL
overexpressing	NULL
various	NULL
members	NULL
of	NULL
the	NULL
Ras-Raf-Erk	NULL
signaling	NULL
cas-cade	NULL
.	NULL

These	NULL
were	NULL
cither	NULL
dominant-negative	NULL
versions	NULL
of	NULL
Ras	NULL
(	NULL
RasN17	NULL
)	NULL
and	NULL
c-Raf	NULL
(	NULL
Raf-C4B	NULL
)	NULL
or	NULL
constitutive-active	NULL
versions	NULL
of	NULL
Ras	NULL
(	NULL
v-H-Ras	NULL
)	NULL
and	NULL
c-Raf	NULL
(	NULL
Raf-BXB	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
a	NULL
vector	NULL
overexpressing	NULL
wild-type	NULL
Erk-2	NULL
was	NULL
transfected	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7B	NULL
,	NULL
overexpression	NULL
of	NULL
all	NULL
active	NULL
versions	NULL
of	NULL
signaling	NULL
molecules	NULL
led	NULL
to	NULL
a	NULL
distinct	NULL
increase	NULL
in	NULL
inducible	NULL
DSE	NULL
activity	NULL
,	NULL
whereas	NULL
dominant-negative	NULL
Raf	NULL
(	NULL
Raf-C4B	NULL
)	NULL
reduced	NULL
DSE	NULL
ac	NULL
4386	NULL
AVOTS	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

G	NULL
RFP	NULL
I	NULL
H	NULL
II	NULL
IV	NULL
a	NULL
¢	NULL
«	NULL
*	NULL
a	NULL
n	NULL
r	NULL
FFZFLZZZZELE	NULL
I-	NULL
«	NULL
se	NULL
«	NULL
me	NULL
G	NULL
R	NULL
FP	NULL
I	NULL
H	NULL
MIV	NULL
frve	NULL
__	NULL
non	NULL
xe	NULL
.433-\s	NULL
_	NULL
...	NULL
_454-.——=	NULL
II	NULL
-	NULL
{	NULL
-	NULL
-enasnao08	NULL
«	NULL
wor	NULL
poe	NULL
woe	NULL
&	NULL
mndpanh	NULL
A	NULL
-447	NULL
+	NULL
ain	NULL
--	NULL
=	NULL
.116°	NULL
GD	NULL
~	NULL
``	NULL
az	NULL
*~	NULL
Shau..-	NULL
--	NULL
as	NULL
-	NULL
Smail	NULL
.._	NULL
Efe	NULL
:	NULL
yess	NULL
2.	NULL
i	NULL
“	NULL
-	NULL
_	NULL
-439°	NULL
aam	NULL
=	NULL
ch	NULL
;	NULL
wite	NULL
.~	NULL
71:33	NULL
re	NULL
436+	NULL
M	NULL
@	NULL
:	NULL
.G	NULL
-435°	NULL
CtP	NULL
102	NULL
%	NULL
3	NULL
4	NULL
5	NULL
60	NULL
70	NULL
80	NULL
9	NULL
10	NULL
11	NULL
12	NULL
1	NULL
2	NULL
%	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
1	NULL
2	NULL
%	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
C	NULL
)	NULL
-262-4.160	NULL
cuFT	NULL
CEG	NULL
.	NULL

GAA	NULL
GACTT	NULL
.	NULL

_/	NULL
r	NULL
DSE	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
from	NULL
Jurkat	NULL
cells	NULL
to	NULL
the	NULL
ERE	NULL
motifs	NULL
of	NULL
palindromic	NULL
DSE	NULL
.	NULL

(	NULL
A	NULL
)	NULL
EMSAs	NULL
.	NULL

A	NULL
4-ug	NULL
amount	NULL
of	NULL
nuclear	NULL
proteins	NULL
from	NULL
uninduced	NULL
Jurkat	NULL
cells	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
or	NULL
cells	NULL
induced	NULL
for	NULL
3	NULL
h	NULL
with	NULL
TPA-ionomycin	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
3	NULL
to	NULL
12	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
a	NULL
DSE	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
12	NULL
)	NULL
or	NULL
an	NULL
ERE-A	NULL
probe	NULL
(	NULL
lane	NULL
1	NULL
)	NULL
followed	NULL
by	NULL
electrophoresis	NULL
on	NULL
a	NULL
4	NULL
%	NULL
native	NULL
PAA	NULL
gel	NULL
.	NULL

For	NULL
specific	NULL
competition	NULL
,	NULL
a	NULL
100-fold	NULL
molar	NULL
excess	NULL
of	NULL
the	NULL
following	NULL
oligonucleotides	NULL
was	NULL
added	NULL
:	NULL
ERE-A	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
ERE-B	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
mutant	NULL
ERE-Ay	NULL
,	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
mutant	NULL
ERE-By	NULL
,	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
,	NULL
a	NULL
TRE	NULL
consensus	NULL
site	NULL
of	NULL
human	NULL
collagenase	NULL
promoter	NULL
(	NULL
lane	NULL
8	NULL
[	NULL
47	NULL
]	NULL
)	NULL
,	NULL
the	NULL
upstream	NULL
promoter	NULL
site	NULL
(	NULL
UPS	NULL
)	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
a	NULL
composite	NULL
AP-1-octamer	NULL
site	NULL
(	NULL
lane	NULL
9	NULL
[	NULL
27	NULL
]	NULL
)	NULL
,	NULL
the	NULL
distal	NULL
purine	NULL
box	NULL
of	NULL
the	NULL
murine	NULL
IL-2	NULL
promoter	NULL
,	NULL
a	NULL
NF-AT	NULL
binding	NULL
site	NULL
(	NULL
lane	NULL
10	NULL
,	NULL
[	NULL
30	NULL
]	NULL
)	NULL
,	NULL
NF-a4	NULL
,	NULL
an	NULL
Ets-binding	NULL
site	NULL
from	NULL
the	NULL
murine	NULL
TCR	NULL
«	NULL
-chain	NULL
promoter	NULL
(	NULL
lane	NULL
11	NULL
[	NULL
22	NULL
]	NULL
)	NULL
,	NULL
and	NULL
a	NULL
consensus	NULL
octamer	NULL
binding	NULL
site	NULL
(	NULL
lane	NULL
12	NULL
)	NULL
.	NULL

The	NULL
DSE-specific	NULL
complexes	NULL
I	NULL
,	NULL
II	NULL
,	NULL
III	NULL
,	NULL
and	NULL
IV	NULL
and	NULL
the	NULL
free	NULL
probe	NULL
(	NULL
FP	NULL
)	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Cu®*-phenanthroline	NULL
footprint	NULL
assays	NULL
.	NULL

DSE	NULL
probes	NULL
labelled	NULL
at	NULL
the	NULL
5	NULL
'	NULL
ends	NULL
of	NULL
the	NULL
upper	NULL
(	NULL
left	NULL
)	NULL
or	NULL
lower	NULL
(	NULL
right	NULL
)	NULL
strands	NULL
were	NULL
incubated	NULL
with	NULL
nuclear	NULL
proteins	NULL
from	NULL
induced	NULL
Jurkat	NULL
cells	NULL
,	NULL
fractionated	NULL
on	NULL
EMSA	NULL
gels	NULL
,	NULL
and	NULL
subjected	NULL
to	NULL
Cu	NULL
*	NULL
-phenantroline	NULL
cleavage	NULL
(	NULL
19	NULL
)	NULL
.	NULL

After	NULL
electrotransfer	NULL
onto	NULL
DES1	NULL
paper	NULL
,	NULL
the	NULL
transferred	NULL
free	NULL
probes	NULL
(	NULL
FP	NULL
)	NULL
and	NULL
the	NULL
complexes	NULL
I	NULL
to	NULL
IV	NULL
(	NULL
see	NULL
panel	NULL
A	NULL
)	NULL
were	NULL
eluted	NULL
and	NULL
fractionated	NULL
on	NULL
a	NULL
12	NULL
%	NULL
PAA	NULL
sequencing	NULL
gel	NULL
,	NULL
along	NULL
with	NULL
G-	NULL
and	NULL
purine	NULL
(	NULL
R	NULL
)	NULL
-specific	NULL
sequencing	NULL
reactions	NULL
.	NULL

The	NULL
G	NULL
residues	NULL
and	NULL
the	NULL
GGAA	NULL
core	NULL
motifs	NULL
within	NULL
the	NULL
DSE	NULL
DNAs	NULL
are	NULL
indicated	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Compilation	NULL
of	NULL
binding	NULL
of	NULL
nuclear	NULL
proteins	NULL
to	NULL
the	NULL
DSE	NULL
DNA	NULL
.	NULL

Thick	NULL
brackets	NULL
,	NULL
binding	NULL
of	NULL
complexes	NULL
II	NULL
to	NULL
IV	NULL
;	NULL
thin	NULL
brackets	NULL
,	NULL
binding	NULL
of	NULL
complex	NULL
I	NULL
to	NULL
DSE	NULL
DNA	NULL
as	NULL
detected	NULL
in	NULL
the	NULL
Cu®*-phenantroline	NULL
footprint	NULL
assays	NULL
(	NULL
see	NULL
panel	NULL
B	NULL
)	NULL
;	NULL
arrows	NULL
,	NULL
palindromic	NULL
ERE	NULL
motifs	NULL
;	NULL
boldface	NULL
,	NULL
core	NULL
of	NULL
GABP	NULL
binding	NULL
motifs	NULL
.	NULL

tivity	NULL
drastically	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
an	NULL
important	NULL
role	NULL
for	NULL
the	NULL
Ras-Raf-Erk	NULL
signaling	NULL
cascade	NULL
in	NULL
induction	NULL
of	NULL
GABP	NULL
factors	NULL
binding	NULL
to	NULL
and	NULL
controlling	NULL
the	NULL
distal	NULL
IL-2	NULL
enhancer	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
work	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
a	NULL
distal	NULL
IL-2	NULL
enhancer	NULL
which	NULL
is	NULL
located	NULL
within	NULL
the	NULL
highly	NULL
conserved	NULL
upstream	NULL
region	NULL
of	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
.	NULL

Due	NULL
to	NULL
the	NULL
binding	NULL
of	NULL
transcription	NULL
factors	NULL
GABPa	NULL
and	NULL
-B	NULL
,	NULL
the	NULL
induction	NULL
conditions	NULL
of	NULL
the	NULL
distal	NULL
enhancer	NULL
differ	NULL
from	NULL
those	NULL
of	NULL
the	NULL
proximal	NULL
IL-2	NULL
promoter	NULL
.	NULL

One	NULL
may	NULL
assume	NULL
that	NULL
external	NULL
signals	NULL
transferred	NULL
through	NULL
the	NULL
classical	NULL
Ras-Raf-Erk	NULL
MAPK	NULL
cascade	NULL
on	NULL
the	NULL
GABP	NULL
factors	NULL
contribute	NULL
to	NULL
induction	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
during	NULL
T-cell	NULL
activation	NULL
.	NULL

GABPa	NULL
and	NULL
-B	NULL
have	NULL
originally	NULL
been	NULL
described	NULL
as	NULL
factors	NULL
controlling	NULL
the	NULL
immediate	NULL
early	NULL
gene	NULL
activation	NULL
of	NULL
herpes	NULL
simplex	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
20	NULL
,	NULL
21	NULL
,	NULL
45	NULL
)	NULL
.	NULL

GABP	NULL
factors	NULL
have	NULL
also	NULL
been	NULL
described	NULL
to	NULL
control	NULL
numerous	NULL
other	NULL
promoters	NULL
,	NULL
including	NULL
the	NULL
cytochrome	NULL
oxidase	NULL
promoter	NULL
(	NULL
13	NULL
,	NULL
48	NULL
)	NULL
.	NULL

However	NULL
,	NULL
there	NULL
are	NULL
only	NULL
a	NULL
few	NULL
reports	NULL
of	NULL
GABP	NULL
factors	NULL
as	NULL
regulators	NULL
of	NULL
lymphoid-specific	NULL
genes	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
GABPa	NULL
and	NULL
-B	NULL
bind	NULL
to	NULL
the	NULL
IL-2	NULL
receptor	NULL
B-chain	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
23	NULL
)	NULL
.	NULL

GABP	NULL
factors	NULL
control	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
long	NULL
terminal	NULL
repeat	NULL
promoter	NULL
in	NULL
Jurkat	NULL
cells	NULL
(	NULL
10	NULL
)	NULL
.	NULL

GABP	NULL
-like	NULL
complexes	NULL
were	NULL
also	NULL
generated	NULL
in	NULL
EMSAs	NULL
of	NULL
B-cell	NULL
proteins	NULL
with	NULL
Ets-like	NULL
binding	NULL
sites	NULL
of	NULL
immunoglobulin	NULL
promoters	NULL
(	NULL
38	NULL
)	NULL
,	NULL
and	NULL
the	NULL
interplay	NULL
between	NULL
GABPs	NULL
and	NULL
the	NULL
Ets-factor	NULL
PU.1	NULL
might	NULL
control	NULL
immunoglobulin	NULL
expression	NULL
and	NULL
the	NULL
weak	NULL
activity	NULL
of	NULL
the	NULL
IL-2	NULL
promoter	NULL
in	NULL
some	NULL
B-cell	NULL
lines	NULL
(	NULL
1	NULL
)	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
an	NULL
important	NULL
role	NULL
of	NULL
GABP	NULL
factors	NULL
in	NULL
gene	NULL
control	NULL
in	NULL
hematopoietic	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
they	NULL
are	NULL
expressed	NULL
at	NULL
high	NULL
concentrations	NULL
.	NULL

GABPa	NULL
is	NULL
a	NULL
55-kDa	NULL
protein	NULL
which	NULL
belongs	NULL
to	NULL
the	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
see	NULL
references	NULL
17	NULL
and	NULL
50	NULL
for	NULL
reviews	NULL
)	NULL
.	NULL

Although	NULL
it	NULL
is	NULL
known	NULL
that	NULL
Ets	NULL
factors	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
transcriptional	NULL
control	NULL
of	NULL
TCR	NULL
genes	NULL
(	NULL
22	NULL
)	NULL
,	NULL
it	NULL
is	NULL
unclear	NULL
whether	NULL
they	NULL
play	NULL
a	NULL
similar	NULL
important	NULL
role	NULL
in	NULL
the	NULL
control	NULL
of	NULL
cytokine	NULL
promoters	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

One	NULL
notable	NULL
exception	NULL
is	NULL
Elf-1	NULL
,	NULL
which	NULL
,	NULL
in	NULL
cooperation	NULL
with	NULL
NF-kB	NULL
factors	NULL
,	NULL
was	NULL
shown	NULL
to	NULL
control	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
IL-2	NULL
receptor	NULL
«	NULL
-chain	NULL
promoter	NULL
(	NULL
18	NULL
)	NULL
and	NULL
,	NULL
along	NULL
with	NULL
AP-1	NULL
,	NULL
the	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
(	NULL
49	NULL
)	NULL
.	NULL

In	NULL
a	NULL
similar	NULL
way	NULL
,	NULL
Elf-1	NULL
appears	NULL
to	NULL
control	NULL
IL-3	NULL
promoter	NULL
activity	NULL
(	NULL
12	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
promoters	NULL
of	NULL
several	NULL
other	NULL
interleukin	NULL
genes	NULL
,	NULL
including	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
contain	NULL
numerous	NULL
Ets-like	NULL
binding	NULL
sequences	NULL
Vou	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
GABP	NULL
FACTORS	NULL
CONTROL	NULL
A	NULL
DISTAL	NULL
IL-2	NULL
ENHANCER	NULL
-	NULL
4387	NULL
ERE-A	NULL
A	NULL
)	NULL
C	NULL
)	NULL
-	NULL
ERE-A	NULL
ERE-B	NULL
ERE-Apy	NULL
-	NULL
ERE-By	NULL
Oct	NULL
E	NULL
+Ti	NULL
+TA	NULL
_|	NULL
+TVCsA	NULL
(	NULL
-t	NULL
|	NULL
-	NULL
PL	NULL
«	NULL
8	NULL
|	NULL
Pla	NULL
8	NULL
[	NULL
Pla	NULL
6|PI	NULL
a	NULL
8	NULL
|Pla	NULL
B|	NULL
Plo	NULL
B	NULL
®	NULL
«	NULL
--	NULL
-	NULL
W	NULL
A4	NULL
;	NULL
-	NULL
*	NULL
way	NULL
se	NULL
»	NULL
san	NULL
amin	NULL
@	NULL
*	NULL
o	NULL
«	NULL
ae	NULL
a	NULL
“	NULL
-.~	NULL
.	NULL

#	NULL
on	NULL
db	NULL
10	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10111213141516171819	NULL
B	NULL
)	NULL
2	NULL
8	NULL
D	NULL
)	NULL
”	NULL
PI	NULL
RCL	NULL
|	NULL
32p	NULL
ECL	NULL
I	NULL
&	NULL
s	NULL
e	NULL
@	NULL
A	NULL
G	NULL
a	NULL
«	NULL
|	NULL
B	NULL
B	NULL
«	NULL
«	NULL
a	NULL
«	NULL
a|n	NULL
g	NULL
B	NULL
B	NULL
1	NULL
P-	NULL
tug	NULL
ws	NULL
``	NULL
ts	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
123456739101112131415161718	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

GABPa	NULL
and	NULL
GABPB	NULL
factors	NULL
bind	NULL
to	NULL
the	NULL
palindromic	NULL
ERE-DSE	NULL
motifs	NULL
of	NULL
the	NULL
distal	NULL
IL-2	NULL
enhancer	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Detection	NULL
of	NULL
specific	NULL
protein	NULL
binding	NULL
to	NULL
the	NULL
ERE-A	NULL
site	NULL
.	NULL

ERE-A	NULL
probes	NULL
were	NULL
incubated	NULL
with	NULL
4	NULL
g	NULL
of	NULL
nuclear	NULL
proteins	NULL
from	NULL
induced	NULL
Jurkat	NULL
cells	NULL
.	NULL

For	NULL
competition	NULL
,	NULL
the	NULL
following	NULL
amounts	NULL
of	NULL
unlabelled	NULL
oligonucleotides	NULL
were	NULL
added	NULL
:	NULL
a	NULL
50-	NULL
,	NULL
100-	NULL
,	NULL
250-	NULL
,	NULL
and	NULL
500-fold	NULL
molar	NULL
excess	NULL
of	NULL
ERE-A	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
5	NULL
,	NULL
respectively	NULL
)	NULL
;	NULL
a	NULL
50-	NULL
,	NULL
100-	NULL
,	NULL
250-	NULL
,	NULL
and	NULL
500-fold	NULL
excess	NULL
of	NULL
ERE-B	NULL
(	NULL
lanes	NULL
6	NULL
to	NULL
9	NULL
,	NULL
respectively	NULL
)	NULL
;	NULL
a	NULL
100-	NULL
,	NULL
250-	NULL
,	NULL
and	NULL
500-fold	NULL
excess	NULL
of	NULL
mutant	NULL
ERE-Ay	NULL
,	NULL
(	NULL
lanes	NULL
10	NULL
to	NULL
12	NULL
,	NULL
respectively	NULL
)	NULL
;	NULL
a	NULL
100-	NULL
,	NULL
250-	NULL
,	NULL
and	NULL
500-fold	NULL
excess	NULL
of	NULL
mutant	NULL
ERE-By	NULL
,	NULL
(	NULL
lanes	NULL
13	NULL
to	NULL
15	NULL
,	NULL
respectively	NULL
)	NULL
;	NULL
and	NULL
a	NULL
250-fold	NULL
excess	NULL
of	NULL
an	NULL
octamer	NULL
consensus	NULL
site	NULL
(	NULL
lane	NULL
16	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
EMSAs	NULL
with	NULL
antibodies	NULL
raised	NULL
against	NULL
GABP	NULL
factors	NULL
.	NULL

Nuclear	NULL
proteins	NULL
from	NULL
induced	NULL
Jurkat	NULL
cells	NULL
were	NULL
incubated	NULL
on	NULL
ice	NULL
for	NULL
10	NULL
min	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
probe	NULL
.	NULL

After	NULL
a	NULL
further	NULL
incubation	NULL
for	NULL
15	NULL
min	NULL
,	NULL
1	NULL
pl	NULL
(	NULL
1	NULL
mg	NULL
of	NULL
protein	NULL
)	NULL
of	NULL
the	NULL
following	NULL
polyclonal	NULL
rabbit	NULL
antibodies	NULL
was	NULL
added	NULL
:	NULL
preimmune	NULL
(	NULL
PT	NULL
)	NULL
serum	NULL
1	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
anti-GABPa	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
anti-Ets-1-Ets-2	NULL
(	NULL
sc-112	NULL
[	NULL
Santa	NULL
Cruz	NULL
}	NULL
)	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
preimmune	NULL
serum	NULL
2	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
,	NULL
and	NULL
anti-Elk-1	NULL
(	NULL
166	NULL
.	NULL

«	NULL
D	NULL
)	NULL
(	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

In	NULL
lane	NULL
1	NULL
,	NULL
no	NULL
antibody	NULL
was	NULL
added	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Preclearing	NULL
experiments	NULL
with	NULL
antibodies	NULL
specific	NULL
for	NULL
GABP	NULL
factors	NULL
.	NULL

Nuclear	NULL
proteins	NULL
from	NULL
uninduced	NULL
Jurkat	NULL
cells	NULL
(	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
and	NULL
11	NULL
to	NULL
13	NULL
)	NULL
or	NULL
cells	NULL
induced	NULL
by	NULL
TPA-ionomycin	NULL
(	NULL
TT	NULL
)	NULL
in	NULL
the	NULL
absence	NULL
(	NULL
lanes	NULL
1	NULL
,	NULL
5	NULL
to	NULL
7	NULL
,	NULL
and	NULL
14	NULL
to	NULL
16	NULL
)	NULL
or	NULL
presence	NULL
(	NULL
lanes	NULL
8	NULL
to	NULL
10	NULL
and	NULL
17	NULL
to	NULL
19	NULL
)	NULL
of	NULL
CsA	NULL
were	NULL
incubated	NULL
with	NULL
GABP-specific	NULL
antibodies	NULL
followed	NULL
by	NULL
incubations	NULL
with	NULL
protein	NULL
A	NULL
agarose	NULL
beads	NULL
and	NULL
,	NULL
after	NULL
a	NULL
short	NULL
centrifugation	NULL
,	NULL
with	NULL
ERE-A	NULL
(	NULL
lanes	NULL
1	NULL
to	NULL
10	NULL
)	NULL
or	NULL
ERE-B	NULL
(	NULL
lanes	NULL
11	NULL
to	NULL
19	NULL
)	NULL
probes	NULL
in	NULL
EMSAs	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Detection	NULL
of	NULL
GABPa	NULL
and	NULL
GABPB	NULL
binding	NULL
to	NULL
the	NULL
ERE-DSE	NULL
motifs	NULL
in	NULL
EMSA-Western	NULL
blot	NULL
experiments	NULL
.	NULL

ERE-A	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
-	NULL
,	NULL
DSE	NULL
(	NULL
lanes	NULL
7	NULL
and	NULL
8	NULL
)	NULL
-	NULL
,	NULL
DSE-Am-	NULL
(	NULL
lane	NULL
9	NULL
)	NULL
-	NULL
,	NULL
and	NULL
DSE-Bm	NULL
(	NULL
lane	NULL
10	NULL
)	NULL
-protein	NULL
complexes	NULL
generated	NULL
after	NULL
incubation	NULL
with	NULL
nuclear	NULL
proteins	NULL
from	NULL
induced	NULL
Jurkat	NULL
cells	NULL
and	NULL
fractionated	NULL
on	NULL
a	NULL
preparative	NULL
native	NULL
5	NULL
%	NULL
PAA	NULL
gel	NULL
were	NULL
electrotransferred	NULL
to	NULL
nitrocellulose	NULL
and	NULL
DE81	NULL
membranes	NULL
.	NULL

In	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
as	NULL
well	NULL
as	NULL
7	NULL
to	NULL
10	NULL
,	NULL
autoradiographs	NULL
of	NULL
transferred	NULL
and	NULL
released	NULL
*°P-labelled	NULL
DNAs	NULL
are	NULL
shown	NULL
.	NULL

Lanes	NULL
3	NULL
to	NULL
6	NULL
and	NULL
11	NULL
to	NULL
18	NULL
show	NULL
reactions	NULL
of	NULL
shifted	NULL
and	NULL
transferred	NULL
proteins	NULL
with	NULL
GABPa	NULL
(	NULL
lanes	NULL
3	NULL
,	NULL
4	NULL
,	NULL
and	NULL
11	NULL
to	NULL
14	NULL
)	NULL
-	NULL
and	NULL
GABPL	NULL
(	NULL
lanes	NULL
5	NULL
,	NULL
6	NULL
,	NULL
and	NULL
15	NULL
to	NULL
18	NULL
)	NULL
-specific	NULL
antibodies	NULL
.	NULL

The	NULL
DSE-ERE-specific	NULL
complexes	NULL
are	NULL
indicated	NULL
.	NULL

Except	NULL
for	NULL
complex	NULL
VI	NULL
,	NULL
which	NULL
seems	NULL
to	NULL
consist	NULL
of	NULL
GABPa	NULL
proteins	NULL
only	NULL
,	NULL
the	NULL
other	NULL
GABP-specific	NULL
complexes	NULL
I	NULL
to	NULL
IV	NULL
consist	NULL
of	NULL
GABP	NULL
heterodimers	NULL
.	NULL

ECL	NULL
,	NULL
enhanced	NULL
chemiluminescence	NULL
.	NULL

to	NULL
which	NULL
Elf-1	NULL
is	NULL
able	NULL
to	NULL
bind	NULL
(	NULL
44	NULL
)	NULL
,	NULL
during	NULL
T-cell	NULL
activation	NULL
these	NULL
sites	NULL
are	NULL
bound	NULL
by	NULL
NF-AT	NULL
factors	NULL
which	NULL
lack	NULL
any	NULL
sequence	NULL
homologies	NULL
with	NULL
Ets	NULL
factors	NULL
.	NULL

This	NULL
does	NULL
not	NULL
exclude	NULL
a	NULL
role	NULL
of	NULL
Ets	NULL
factors	NULL
in	NULL
lymphokine	NULL
gene	NULL
control	NULL
.	NULL

Overexpression	NULL
of	NULL
Ets-1	NULL
antisense	NULL
RNA	NULL
in	NULL
Jurkat	NULL
cells	NULL
led	NULL
to	NULL
a	NULL
pronounced	NULL
increase	NULL
in	NULL
IL-2	NULL
synthesis	NULL
and	NULL
IL-2	NULL
promoter	NULL
activity	NULL
,	NULL
suggesting	NULL
a	NULL
role	NULL
for	NULL
Ets-1	NULL
in	NULL
the	NULL
suppression	NULL
of	NULL
IL-2	NULL
transcription	NULL
in	NULL
unstimulated	NULL
T	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
Ets-1	NULL
is	NULL
strongly	NULL
expressed	NULL
(	NULL
33	NULL
)	NULL
.	NULL

The	NULL
two	NULL
highly	NULL
related	NULL
murine	NULL
GABPB	NULL
polypeptides	NULL
GABPB1	NULL
and	NULL
-2	NULL
,	NULL
which	NULL
are	NULL
encoded	NULL
by	NULL
two	NULL
unlinked	NULL
genes	NULL
(	NULL
8	NULL
)	NULL
,	NULL
contain	NULL
tandem	NULL
series	NULL
of	NULL
approximately	NULL
30	NULL
amino	NULL
acids	NULL
which	NULL
share	NULL
sequence	NULL
homologies	NULL
with	NULL
the	NULL
notch-ankyrin	NULL
repeats	NULL
of	NULL
several	NULL
other	NULL
transcription	NULL
factors	NULL
.	NULL

Although	NULL
alone	NULL
is	NULL
unable	NULL
to	NULL
bind	NULL
to	NULL
DNA	NULL
,	NULL
it	NULL
is	NULL
required	NULL
for	NULL
the	NULL
avid	NULL
binding	NULL
of	NULL
GABP	NULL
factors	NULL
to	NULL
their	NULL
target	NULL
sequence	NULL
GCCGGAAGT	NULL
(	NULL
4	NULL
)	NULL
,	NULL
which	NULL
is	NULL
often	NULL
arranged	NULL
in	NULL
direct	NULL
repeats	NULL
.	NULL

The	NULL
GABP	NULL
binding	NULL
site	NULL
within	NULL
the	NULL
ERE-A	NULL
of	NULL
the	NULL
distal	NULL
IL-2	NULL
enhancer	NULL
shares	NULL
7	NULL
of	NULL
9	NULL
bp	NULL
with	NULL
the	NULL
GABP	NULL
consensus	NULL
sequence	NULL
,	NULL
whereas	NULL
the	NULL
weaker	NULL
binding	NULL
site	NULL
ERE-B	NULL
shares	NULL
only	NULL
5	NULL
bp	NULL
with	NULL
the	NULL
consensus	NULL
motif	NULL
(	NULL
Fig	NULL
.	NULL

5C	NULL
)	NULL
.	NULL

However	NULL
,	NULL
these	NULL
sequences	NULL
are	NULL
located	NULL
approximately	NULL
15	NULL
bp	NULL
apart	NULL
in	NULL
a	NULL
palindromic	NULL
configuration	NULL
which	NULL
is	NULL
very	NULL
important	NULL
for	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
distal	NULL
enhancer	NULL
.	NULL

Generation	NULL
of	NULL
the	NULL
huge	NULL
DNA-protein	NULL
complex	NULL
I	NULL
is	NULL
specific	NULL
for	NULL
the	NULL
palindromic	NULL
DSE	NULL
probe	NULL
,	NULL
and	NULL
it	NULL
is	NULL
very	NULL
likely	NULL
that	NULL
the	NULL
formation	NULL
of	NULL
this	NULL
(	NULL
tetrameric	NULL
?	NULL
)	NULL

complex	NULL
is	NULL
important	NULL
for	NULL
the	NULL
strong	NULL
DSE	NULL
induction	NULL
.	NULL

Tandemly	NULL
arranged	NULL
GABP	NULL
binding	NULL
sites	NULL
have	NULL
been	NULL
detected	NULL
in	NULL
several	NULL
other	NULL
promoters	NULL
(	NULL
see	NULL
,	NULL
e.g	NULL
.	NULL

,	NULL
reference	NULL
13	NULL
)	NULL
,	NULL
and	NULL
the	NULL
interaction	NULL
between	NULL
two	NULL
and	NULL
more	NULL
heterodimeric	NULL
GABP	NULL
factors	NULL
appears	NULL
to	NULL
be	NULL
important	NULL
for	NULL
activation	NULL
by	NULL
these	NULL
factors	NULL
.	NULL

The	NULL
activity	NULL
of	NULL
many	NULL
,	NULL
if	NULL
not	NULL
all	NULL
,	NULL
members	NULL
of	NULL
the	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
appears	NULL
to	NULL
be	NULL
regulated	NULL
by	NULL
phosphoryla-tion	NULL
.	NULL

Mitogenic	NULL
stimulation	NULL
of	NULL
thymocytes	NULL
and	NULL
Jurkat	NULL
cells	NULL
results	NULL
in	NULL
a	NULL
Ca**-dependent	NULL
phosphorylation	NULL
of	NULL
Ets-1	NULL
or	NULL
Ets-2	NULL
protein	NULL
(	NULL
11	NULL
,	NULL
28	NULL
)	NULL
.	NULL

Well-characterized	NULL
Ets	NULL
factors	NULL
,	NULL
whose	NULL
activity	NULL
is	NULL
induced	NULL
within	NULL
seconds	NULL
upon	NULL
mitogenic	NULL
stimulation	NULL
of	NULL
cells	NULL
,	NULL
4388	NULL
AVOTS	NULL
ET	NULL
AL	NULL
.	NULL

o	NULL
A	NULL
)	NULL
C	NULL
Vector	NULL
I	NULL
©	NULL
GaBP	NULL
&	NULL
B	NULL
G	NULL
GABP	NULL
&	NULL
/B+BXB	NULL
Fold	NULL
activation	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

UJ	NULL
Ne/	NULL
®	NULL
Fold	NULL
activation	NULL
0~	NULL
Activator	NULL
:	NULL
-	NULL
Erk	NULL
?	NULL

BXB	NULL
Cab	NULL
4xDSE	NULL
--	NULL
-	NULL
4xDSE	NULL
-Am	NULL
v-H-Ras	NULL
-	NULL
RasN17	NULL
Erk	NULL
?	NULL

Reporter	NULL
:	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

GABP	NULL
factors	NULL
contribute	NULL
to	NULL
c-Raf-mediated	NULL
increase	NULL
of	NULL
IL-2	NULL
promoter-enhancer	NULL
activity	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Inhibition	NULL
of	NULL
GABP	NULL
binding	NULL
to	NULL
the	NULL
distal	NULL
IL-2	NULL
enhancer	NULL
impairs	NULL
IL-2	NULL
induction	NULL
.	NULL

A	NULL
0.6-ug	NULL
amount	NULL
of	NULL
tkCAT	NULL
constructs	NULL
containing	NULL
four	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
DSE	NULL
(	NULL
4xDSE	NULL
)	NULL
,	NULL
a	NULL
mutated	NULL
DSE	NULL
(	NULL
4xDSE-Am	NULL
)	NULL
,	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
wild-type	NULL
distal	NULL
enhancer	NULL
(	NULL
2xDIST	NULL
)	NULL
or	NULL
of	NULL
the	NULL
distal	NULL
enhancer	NULL
mutated	NULL
in	NULL
the	NULL
ERE-A	NULL
(	NULL
2xDIST-Am	NULL
)	NULL
,	NULL
or	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
IL-2	NULL
wild-type	NULL
5	NULL
'	NULL
region	NULL
(	NULL
-583/+5	NULL
)	NULL
or	NULL
the	NULL
same	NULL
fragment	NULL
mutated	NULL
in	NULL
the	NULL
ERE-A	NULL
(	NULL
-583/+5-Am	NULL
)	NULL
was	NULL
cotransfected	NULL
each	NULL
with	NULL
1	NULL
ug	NULL
of	NULL
GABPa	NULL
and	NULL
-B	NULL
expression	NULL
vectors	NULL
into	NULL
A	NULL
3.01	NULL
T-lymphoma	NULL
cells	NULL
by	NULL
using	NULL
DMRIE	NULL
(	NULL
GIBCO	NULL
)	NULL
,	NULL
without	NULL
or	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
Raf-BXB	NULL
expression	NULL
vector	NULL
as	NULL
indicated	NULL
.	NULL

After	NULL
40	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
harvested	NULL
and	NULL
used	NULL
for	NULL
CAT	NULL
assays	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Ras-Raf-Erk	NULL
proteins	NULL
enhance	NULL
the	NULL
induction	NULL
of	NULL
GABP-mediated	NULL
DSE	NULL
activity	NULL
.	NULL

A	NULL
1-pg	NULL
amount	NULL
of	NULL
DNA	NULL
from	NULL
4xDSE-tkCAT	NULL
or	NULL
4xDSE-Am-tkCAT	NULL
constructs	NULL
was	NULL
cotransfected	NULL
with	NULL
5	NULL
g	NULL
of	NULL
cDNA	NULL
vectors	NULL
overexpressing	NULL
Erk-2	NULL
or	NULL
constitutive-active	NULL
versions	NULL
of	NULL
c-Raf	NULL
(	NULL
Raf-BXB	NULL
)	NULL
and	NULL
Ras	NULL
(	NULL
v-H-Ras	NULL
)	NULL
or	NULL
dominant-negative	NULL
versions	NULL
of	NULL
c-Raf	NULL
(	NULL
Raf-C4B	NULL
)	NULL
and	NULL
Ras	NULL
(	NULL
RasN17	NULL
)	NULL
.	NULL

After	NULL
20	NULL
h	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
induced	NULL
with	NULL
TPA	NULL
for	NULL
24	NULL
h.	NULL
The	NULL
fold	NULL
induction	NULL
of	NULL
CAT	NULL
activity	NULL
values	NULL
were	NULL
calculated	NULL
as	NULL
the	NULL
activities	NULL
of	NULL
cells	NULL
cotransfected	NULL
with	NULL
the	NULL
various	NULL
expression	NULL
vectors	NULL
versus	NULL
the	NULL
activities	NULL
of	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
reporter	NULL
gene	NULL
alone	NULL
.	NULL

are	NULL
Elk-1	NULL
and	NULL
its	NULL
relatives	NULL
,	NULL
SAP-1	NULL
and	NULL
SAP-2	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
Erk	NULL
,	NULL
SAPK/JNK	NULL
,	NULL
and	NULL
p38	NULL
MAPK	NULL
pathways	NULL
stimulates	NULL
the	NULL
rapid	NULL
phosphorylation	NULL
of	NULL
several	NULL
Ser	NULL
residues	NULL
within	NULL
the	NULL
C-terminal	NULL
transactivation	NULL
domains	NULL
of	NULL
these	NULL
transcription	NULL
factors	NULL
(	NULL
see	NULL
reference	NULL
46	NULL
for	NULL
a	NULL
recent	NULL
review	NULL
)	NULL
.	NULL

These	NULL
phosphorylation	NULL
events	NULL
facilitate	NULL
ternary	NULL
complex	NULL
formation	NULL
with	NULL
the	NULL
serum-responsive	NULL
factor	NULL
and	NULL
induction	NULL
of	NULL
the	NULL
c-fos	NULL
promoter	NULL
(	NULL
29	NULL
)	NULL
.	NULL

In	NULL
Jurkat	NULL
cells	NULL
,	NULL
the	NULL
activity	NULL
of	NULL
GABP	NULL
binding	NULL
sites	NULL
is	NULL
also	NULL
induced	NULL
by	NULL
stimuli	NULL
of	NULL
these	NULL
MAPK	NULL
pathways	NULL
,	NULL
in	NULL
particular	NULL
by	NULL
the	NULL
phorbol	NULL
ester	NULL
TPA	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
and	NULL
UV	NULL
light	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Although	NULL
we	NULL
did	NULL
not	NULL
observe	NULL
marked	NULL
alterations	NULL
in	NULL
the	NULL
DNA	NULL
binding	NULL
of	NULL
GABP	NULL
factors	NULL
,	NULL
i.e	NULL
.	NULL

,	NULL
in	NULL
the	NULL
generation	NULL
of	NULL
complexes	NULL
II	NULL
to	NULL
IV	NULL
after	NULL
TPA-ionomycin	NULL
treatment	NULL
,	NULL
these	NULL
or	NULL
other	NULL
stimuli	NULL
could	NULL
also	NULL
facilitate	NULL
the	NULL
generation	NULL
of	NULL
larger	NULL
GABP-containing	NULL
complexes	NULL
.	NULL

One	NULL
candidate	NULL
for	NULL
such	NULL
a	NULL
ternary	NULL
complex	NULL
is	NULL
complex	NULL
I	NULL
,	NULL
which	NULL
contains	NULL
GABP	NULL
and	NULL
,	NULL
probably	NULL
,	NULL
additional	NULL
proteins	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
conditions	NULL
for	NULL
the	NULL
generation	NULL
of	NULL
putative	NULL
ternary	NULL
GABP	NULL
complexes	NULL
,	NULL
EMSAs	NULL
with	NULL
the	NULL
DSE	NULL
as	NULL
a	NULL
probe	NULL
and	NULL
nuclear	NULL
proteins	NULL
from	NULL
Jurkat	NULL
cells	NULL
which	NULL
have	NULL
been	NULL
induced	NULL
with	NULL
various	NULL
stimuli	NULL
are	NULL
in	NULL
progress	NULL
.	NULL

The	NULL
stimulatory	NULL
effect	NULL
of	NULL
constitutive	NULL
active	NULL
versions	NULL
of	NULL
Ras	NULL
,	NULL
c-Raf	NULL
,	NULL
and	NULL
Erk-2	NULL
signaling	NULL
molecules	NULL
and	NULL
the	NULL
inhibition	NULL
of	NULL
GABP	NULL
activity	NULL
by	NULL
C4b	NULL
,	NULL
a	NULL
dominant-negative	NULL
version	NULL
of	NULL
c-Raf	NULL
,	NULL
indicate	NULL
that	NULL
the	NULL
GABP	NULL
factors	NULL
are	NULL
targets	NULL
of	NULL
the	NULL
Ras-Raf-Erk	NULL
signaling	NULL
cascade	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
is	NULL
strongly	NULL
supported	NULL
by	NULL
the	NULL
phosphorylation	NULL
of	NULL
GABP	NULL
proteins	NULL
by	NULL
Erk-2	NULL
in	NULL
vitro	NULL
and	NULL
,	NULL
upon	NULL
TPA-serum	NULL
stimulation	NULL
,	NULL
in	NULL
vivo	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
UV	NULL
light	NULL
irradiation	NULL
and	NULL
methlyl	NULL
methane	NULL
sulfonate	NULL
,	NULL
which	NULL
are	NULL
strong	NULL
inducers	NULL
of	NULL
SAPK/JNK	NULL
and	NULL
p38	NULL
kinases	NULL
(	NULL
46	NULL
)	NULL
,	NULL
also	NULL
enhance	NULL
GABP-mediated	NULL
activity	NULL
and	NULL
,	NULL
in	NULL
concert	NULL
with	NULL
TPA	NULL
,	NULL
exert	NULL
a	NULL
strong	NULL
synergistic	NULL
effect	NULL
on	NULL
GABP-mediated	NULL
gene	NULL
induction	NULL
(	NULL
1a	NULL
)	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
GABP	NULL
factors	NULL
might	NULL
be	NULL
modulated	NULL
not	NULL
only	NULL
by	NULL
the	NULL
classical	NULL
Ras-Raf-Erk	NULL
cascade	NULL
but	NULL
rather	NULL
by	NULL
the	NULL
convergence	NULL
of	NULL
several	NULL
signaling	NULL
pathways	NULL
on	NULL
GABP	NULL
transcriptional	NULL
complexes	NULL
.	NULL

It	NULL
remains	NULL
to	NULL
be	NULL
shown	NULL
in	NULL
detail	NULL
how	NULL
the	NULL
activation	NULL
of	NULL
these	NULL
MAPK	NULL
pathways	NULL
contributes	NULL
to	NULL
IL-2	NULL
induction	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
are	NULL
indebted	NULL
to	NULL
Elke	NULL
Leibold	NULL
and	NULL
Nona	NULL
Pictrowski	NULL
for	NULL
excellent	NULL
technical	NULL
assistance	NULL
.	NULL

For	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
,	NULL
we	NULL
thank	NULL
Tan	NULL
Johnston	NULL
.	NULL

For	NULL
gifts	NULL
of	NULL
reagents	NULL
,	NULL
we	NULL
thank	NULL
P.	NULL
Angel	NULL
,	NULL
C.	NULL
Baldari	NULL
,	NULL
J.	NULL
Leiden	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
A.	NULL
Nordheim	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Telford	NULL
.	NULL

We	NULL
thank	NULL
E.	NULL
Grens	NULL
(	NULL
Riga	NULL
,	NULL
Latvia	NULL
)	NULL
for	NULL
his	NULL
interest	NULL
and	NULL
continuous	NULL
support	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Sonderforschungsbereich	NULL
165	NULL
(	NULL
Wiirzburg	NULL
,	NULL
Germany	NULL
)	NULL
of	NULL
the	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
,	NULL
the	NULL
Wilhelm	NULL
Sander-Stiftung	NULL
,	NULL
and	NULL
the	NULL
Volkswagenstiftung	NULL
.	NULL

A.A.	NULL
was	NULL
also	NULL
supported	NULL
by	NULL
an	NULL
EC	NULL
grant	NULL
for	NULL
Cooperation	NULL
in	NULL
Science	NULL
and	NULL
Technology	NULL
with	NULL
Central	NULL
and	NULL
Eastern	NULL
European	NULL
Countries	NULL
(	NULL
ERB-CIPA-CT-92-0108	NULL
)	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Avots	NULL
,	NULL
A	NULL
.	NULL

Unpublished	NULL
results	NULL
.	NULL

la.Avots	NULL
,	NULL
A.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

2	NULL
.	NULL

Baldari	NULL
,	NULL
C.	NULL
T.	NULL
,	NULL
A.	NULL
Heguy	NULL
,	NULL
and	NULL
J.	NULL
F.	NULL
Telford	NULL
.	NULL

1993.	NULL
ras	NULL
protein	NULL
activity	NULL
is	NULL
essential	NULL
for	NULL
T-cell	NULL
antigen	NULL
receptor	NULL
signal	NULL
transduction	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:2693-2698	NULL
.	NULL

2a.Boshart	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Kliippel	NULL
,	NULL
A.	NULL
Schmidt	NULL
,	NULL
G.	NULL
Schiitz	NULL
,	NULL
and	NULL
B.	NULL
Luckow	NULL
.	NULL

1992	NULL
.	NULL

Reporter	NULL
constructs	NULL
with	NULL
low	NULL
background	NULL
activity	NULL
utilizing	NULL
the	NULL
cat	NULL
gene	NULL
.	NULL

Gene	NULL
110:129-130	NULL
.	NULL

3	NULL
.	NULL

Brombacher	NULL
,	NULL
F.	NULL
,	NULL
T.	NULL
Schiifé	NULL
.	NULL

Wei	NULL
tein	NULL
,	NULL
C.	NULL
Tschopp	NULL
,	NULL
E.	NULL
Andersen	NULL
,	NULL
K.	NULL
Burki	NULL
,	NULL
and	NULL
G.	NULL
Baumann	NULL
.	NULL

1994	NULL
.	NULL

IL-2	NULL
promoter-driven	NULL
lacZ	NULL
expression	NULL
as	NULL
a	NULL
monitoring	NULL
tool	NULL
for	NULL
IL-2	NULL
expression	NULL
in	NULL
primary	NULL
T	NULL
cells	NULL
of	NULL
transgenic	NULL
mice	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

6:186-197	NULL
.	NULL

4	NULL
.	NULL

Brown	NULL
,	NULL
T.	NULL
A.	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1992	NULL
.	NULL

Specificities	NULL
of	NULL
protein-protein	NULL
and	NULL
protein-DNA	NULL
interaction	NULL
of	NULL
GABPa	NULL
and	NULL
two	NULL
newly	NULL
defined	NULL
ets-related	NULL
proteins	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

62502-2512	NULL
.	NULL

5	NULL
.	NULL

Bruder	NULL
,	NULL
J.	NULL
T.	NULL
,	NULL
G.	NULL
Heidecker	NULL
,	NULL
and	NULL
U.	NULL
R.	NULL
Rapp	NULL
.	NULL

1992	NULL
.	NULL

Serum-	NULL
,	NULL
TPA-	NULL
,	NULL
and	NULL
Ras-induced	NULL
expression	NULL
from	NULL
Ap-1/Ets-driven	NULL
promoters	NULL
requires	NULL
Raf-1	NULL
ki-nase	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6545-556	NULL
.	NULL

6	NULL
.	NULL

Cantrell	NULL
,	NULL
D.	NULL
1996	NULL
.	NULL

T	NULL
cell	NULL
antigen	NULL
receptor	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14:259-274	NULL
.	NULL

7	NULL
.	NULL

Christianson	NULL
,	NULL
A.	NULL
M.	NULL
K.	NULL
,	NULL
and	NULL
F.	NULL
C.	NULL
Kafatos	NULL
.	NULL

1993	NULL
.	NULL

Antibody	NULL
detection	NULL
of	NULL
protein	NULL
complexes	NULL
bound	NULL
to	NULL
DNA	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

21:4416-4417	NULL
.	NULL

8.	NULL
de	NULL
la	NULL
Brousse	NULL
,	NULL
F.	NULL
C.	NULL
,	NULL
E.	NULL
H.	NULL
Birkenmeier	NULL
,	NULL
D.	NULL
S.	NULL
King	NULL
,	NULL
L.	NULL
B.	NULL
Rowe	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1994	NULL
.	NULL

Molecular	NULL
and	NULL
genetic	NULL
characterization	NULL
of	NULL
GABPB	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:1853-1865	NULL
.	NULL

9	NULL
.	NULL

Demezuk	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Harbers	NULL
,	NULL
and	NULL
B.	NULL
Vennstrom	NULL
.	NULL

1993	NULL
.	NULL

Identification	NULL
and	NULL
analysis	NULL
of	NULL
all	NULL
components	NULL
of	NULL
a	NULL
gel	NULL
retardation	NULL
assay	NULL
by	NULL
combination	NULL
with	NULL
immu-noblotting	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
90:2574-2578	NULL
.	NULL

10	NULL
.	NULL

Flory	NULL
,	NULL
E.	NULL
,	NULL
A.	NULL
Hoffmeyer	NULL
,	NULL
U.	NULL
Smola	NULL
,	NULL
U.	NULL
R.	NULL
Rapp	NULL
,	NULL
and	NULL
J.	NULL
T.	NULL
Bruder	NULL
.	NULL

1996	NULL
.	NULL

Raf-1	NULL
kinase	NULL
targets	NULL
GA-binding	NULL
protein	NULL
(	NULL
GABP	NULL
)	NULL
in	NULL
transcriptional	NULL
regulation	NULL
of	NULL
Vor	NULL
.	NULL

17	NULL
,	NULL
1997	NULL
11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

P	NULL
29	NULL
.	NULL

30	NULL
.	NULL

31.	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
promoter	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

70:2260-2268	NULL
.	NULL

Fujiwara	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Koizumi	NULL
,	NULL
R.	NULL
J.	NULL
Fisher	NULL
,	NULL
N.	NULL
K.	NULL
Bhat	NULL
,	NULL
and	NULL
T.	NULL
S.	NULL
Papas	NULL
.	NULL

1990	NULL
.	NULL

Phosphorylation	NULL
of	NULL
the	NULL
Ets-2	NULL
protein	NULL
:	NULL
regulation	NULL
by	NULL
the	NULL
T-cell	NULL
antigen	NULL
receptor-CD3	NULL
complex	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

10:1249-1253	NULL
.	NULL

Gottschalk	NULL
,	NULL
L.	NULL
R.	NULL
,	NULL
D.	NULL
M.	NULL
Giannola	NULL
,	NULL
and	NULL
S.	NULL
G.	NULL
Emerson	NULL
.	NULL

1993	NULL
.	NULL

Molecular	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
IL-3	NULL
gene	NULL
:	NULL
inducible	NULL
T	NULL
cell-restricted	NULL
expression	NULL
required	NULL
intact	NULL
AP-1	NULL
and	NULL
Elf-1	NULL
nuclear	NULL
protein	NULL
binding	NULL
sites	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1681-1692	NULL
.	NULL

Gugneja	NULL
,	NULL
S.	NULL
,	NULL
J.	NULL
V.	NULL
Virbasius	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Scarpulla	NULL
.	NULL

1995	NULL
.	NULL

Four	NULL
structurally	NULL
distinct	NULL
,	NULL
non-DNA-binding	NULL
subunits	NULL
of	NULL
human	NULL
nuclear	NULL
respiratory	NULL
factor	NULL
2	NULL
share	NULL
a	NULL
conserved	NULL
transcriptional	NULL
activation	NULL
domain	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:102-111	NULL
.	NULL

Izquierdo	NULL
,	NULL
M.	NULL
,	NULL
S.	NULL
J.	NULL
Leevers	NULL
,	NULL
C.	NULL
J.	NULL
Marshall	NULL
,	NULL
and	NULL
D.	NULL
Cantrell	NULL
.	NULL

1993.	NULL
p21	NULL
'	NULL
``	NULL
``	NULL
*	NULL
couples	NULL
the	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
to	NULL
extracellular	NULL
signal-regulated	NULL
kinase	NULL
2	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1199-1208	NULL
.	NULL

Jankevics	NULL
,	NULL
E.	NULL
,	NULL
G.	NULL
Makarenkova	NULL
,	NULL
A.	NULL
Tsimanis	NULL
,	NULL
and	NULL
E.	NULL
Grens	NULL
.	NULL

1994	NULL
.	NULL

Structure	NULL
and	NULL
analysis	NULL
of	NULL
the	NULL
5°	NULL
flanking	NULL
region	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
gene	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1217:235-238	NULL
.	NULL

Janknecht	NULL
,	NULL
R.	NULL
,	NULL
W.	NULL
H.	NULL
Ernst	NULL
,	NULL
V.	NULL
Pingoud	NULL
,	NULL
and	NULL
A.	NULL
Nordheim	NULL
.	NULL

1993	NULL
.	NULL

Activation	NULL
of	NULL
ternary	NULL
complex	NULL
factor	NULL
Elk-1	NULL
by	NULL
MAP	NULL
kinases	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:5097-5104	NULL
.	NULL

Janknecht	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
A.	NULL
Nordheim	NULL
.	NULL

1993	NULL
.	NULL

Gene	NULL
regulation	NULL
by	NULL
Ets	NULL
proteins	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1155:346-356	NULL
.	NULL

John	NULL
,	NULL
S.	NULL
,	NULL
R.	NULL
B.	NULL
Reeves	NULL
,	NULL
J.-X	NULL
.	NULL

Lin	NULL
,	NULL
R.	NULL
Child	NULL
,	NULL
J.	NULL
M.	NULL
Leiden	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1995	NULL
.	NULL

Regulation	NULL
of	NULL
cell-type-specific	NULL
interleukin-2	NULL
receptor	NULL
«	NULL
-chain	NULL
gene	NULL
expression	NULL
:	NULL
potential	NULL
role	NULL
of	NULL
physical	NULL
interactions	NULL
between	NULL
Elf-1	NULL
,	NULL
HMG-I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
and	NULL
NF-xB	NULL
family	NULL
proteins	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
:	NULL
1786-1796	NULL
.	NULL

Kuwabara	NULL
,	NULL
M.	NULL
D.	NULL
,	NULL
and	NULL
D.	NULL
S.	NULL
Sigman	NULL
.	NULL

1987	NULL
.	NULL

Footprinting	NULL
DNA-protein	NULL
complexes	NULL
in	NULL
situ	NULL
following	NULL
gel	NULL
retardation	NULL
assays	NULL
using	NULL
1,10-phenanthroline-copper	NULL
ion	NULL
:	NULL
Escherichia	NULL
coli	NULL
RNA	NULL
polymerase-lac	NULL
promoter	NULL
complexes	NULL
.	NULL

Biochemistry	NULL
26:7234-7238	NULL
.	NULL

LaMarco	NULL
,	NULL
K.	NULL
,	NULL
C.	NULL
C.	NULL
Thompson	NULL
,	NULL
B.	NULL
P.	NULL
Byers	NULL
,	NULL
E.	NULL
M.	NULL
Walton	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
of	NULL
Ets-	NULL
and	NULL
Notch-related	NULL
subunits	NULL
in	NULL
GA	NULL
binding	NULL
protein	NULL
.	NULL

Science	NULL
253:789-792	NULL
.	NULL

LaMarco	NULL
,	NULL
K.	NULL
L.	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1989	NULL
.	NULL

Purification	NULL
of	NULL
a	NULL
set	NULL
of	NULL
cellular	NULL
polypeptides	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
purine-rich	NULL
cis-regulatory	NULL
element	NULL
of	NULL
herpes	NULL
simplex	NULL
virus	NULL
immediately	NULL
carly	NULL
genes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

3:1372-1383	NULL
.	NULL

Leiden	NULL
,	NULL
J.	NULL
M.	NULL
1993	NULL
.	NULL

Transcriptional	NULL
regulation	NULL
of	NULL
T	NULL
cell	NULL
receptor	NULL
genes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

11:539-570	NULL
.	NULL

Lin	NULL
,	NULL
JX	NULL
,	NULL
,	NULL
N.	NULL
K.	NULL
Bhat	NULL
,	NULL
S.	NULL
John	NULL
,	NULL
W.	NULL
S.	NULL
Queale	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
B-chain	NULL
gene	NULL
promoter	NULL
:	NULL
regulation	NULL
of	NULL
promoter	NULL
activity	NULL
by	NULL
ets	NULL
gene	NULL
products	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13:6201-6210	NULL
.	NULL

Liu	NULL
,	NULL
J	NULL
.	NULL

1993	NULL
.	NULL

FK506	NULL
and	NULL
cyclosporin	NULL
,	NULL
molecular	NULL
probes	NULL
for	NULL
studying	NULL
intracellular	NULL
signal	NULL
transduction	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
14:290-295	NULL
.	NULL

Novak	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
P.	NULL
M.	NULL
White	NULL
,	NULL
and	NULL
E.	NULL
V.	NULL
Rothenberg	NULL
.	NULL

1990	NULL
.	NULL

Regulatory	NULL
anatomy	NULL
of	NULL
the	NULL
murine	NULL
interleukin-2	NULL
gene	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

18:4523-4533	NULL
.	NULL

Owaki	NULL
,	NULL
H.	NULL
,	NULL
R.	NULL
Varma	NULL
,	NULL
B.	NULL
Gillis	NULL
,	NULL
J.	NULL
T.	NULL
Bruder	NULL
,	NULL
U.	NULL
R.	NULL
Rapp	NULL
,	NULL
L.	NULL
S.	NULL
Davis	NULL
,	NULL
and	NULL
T.	NULL
D.	NULL
Geppert	NULL
.	NULL

1993	NULL
.	NULL

Raf-1	NULL
is	NULL
required	NULL
for	NULL
T	NULL
cell	NULL
IL2	NULL
production	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:4367-4373	NULL
.	NULL

Pfeuffer	NULL
,	NULL
L	NULL
,	NULL
S.	NULL
Klein-HeBling	NULL
,	NULL
A.	NULL
Heinfling	NULL
,	NULL
S.	NULL
Chuypilo	NULL
,	NULL
C.	NULL
Escher	NULL
,	NULL
T.	NULL
Brabletz	NULL
,	NULL
B.	NULL
Hentsch	NULL
,	NULL
H.	NULL
Schwarzenbach	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1994	NULL
.	NULL

Octamer	NULL
factors	NULL
exert	NULL
a	NULL
dual	NULL
effect	NULL
on	NULL
the	NULL
IL-2	NULL
and	NULL
IL-4	NULL
promoters	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

153:5572-5585	NULL
.	NULL

P.	NULL
,	NULL
K.	NULL
E.	NULL
Boulukos	NULL
,	NULL
J.	NULL
C.	NULL
Gesquiere	NULL
,	NULL
D.	NULL
Stehelin	NULL
,	NULL
and	NULL
J.	NULL
Ghysdael	NULL
.	NULL

1988	NULL
.	NULL

Mitogenic	NULL
stimulation	NULL
of	NULL
thymocytes	NULL
results	NULL
in	NULL
the	NULL
calcium-dependent	NULL
phosphorylation	NULL
of	NULL
c-ets-1	NULL
proteins	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:977-983	NULL
.	NULL

Price	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
F.	NULL
H.	NULL
Cruzalegui	NULL
,	NULL
and	NULL
R.	NULL
Treisman	NULL
.	NULL

1996	NULL
.	NULL

The	NULL
p38	NULL
and	NULL
Erk	NULL
MAP	NULL
kinase	NULL
pathways	NULL
cooperate	NULL
to	NULL
activate	NULL
ternary	NULL
complex	NULL
factors	NULL
and	NULL
c-fos	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
UV	NULL
light	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15:6552-6563	NULL
.	NULL

Randak	NULL
,	NULL
C.	NULL
,	NULL
T.	NULL
Brabletz	NULL
,	NULL
M.	NULL
Hergenriither	NULL
,	NULL
I.	NULL
Sobotta	NULL
,	NULL
and	NULL
E.	NULL
Serfling	NULL
.	NULL

1990	NULL
.	NULL

Cyclosporin	NULL
A	NULL
suppresses	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
gene	NULL
by	NULL
inhibiting	NULL
the	NULL
binding	NULL
of	NULL
lymphocyte-specific	NULL
factors	NULL
to	NULL
the	NULL
IL-2	NULL
enhancer	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

92529-2536	NULL
.	NULL

Rao	NULL
,	NULL
A	NULL
.	NULL

1994	NULL
.	NULL

NF-ATp	NULL
:	NULL
a	NULL
transcriptional	NULL
factor	NULL
required	NULL
for	NULL
the	NULL
co-ordinate	NULL
induction	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
15:274-281	NULL
.	NULL

GABP	NULL
32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

FACTORS	NULL
CONTROL	NULL
A	NULL
DISTAL	NULL
IL-2	NULL
ENHANCER	NULL
-	NULL
4389	NULL
Rapp	NULL
,	NULL
U.	NULL
R.	NULL
,	NULL
J.	NULL
T.	NULL
Bruder	NULL
,	NULL
and	NULL
J.	NULL
Troppmair	NULL
.	NULL

1994	NULL
.	NULL

Role	NULL
of	NULL
the	NULL
Raf	NULL
signal	NULL
transduction	NULL
pathway	NULL
in	NULL
fos/jun	NULL
regulation	NULL
and	NULL
determination	NULL
of	NULL
cell	NULL
fates	NULL
,	NULL
p.	NULL
221-247	NULL
.	NULL

In	NULL
P.	NULL
Angel	NULL
and	NULL
P.	NULL
Herrlich	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
The	NULL
fos	NULL
and	NULL
jun	NULL
families	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

CRC	NULL
Press	NULL
Inc.	NULL
,	NULL
Boca	NULL
Raton	NULL
,	NULL
Fla.	NULL
Romano-Spica	NULL
,	NULL
V.	NULL
,	NULL
P.	NULL
Georgiou	NULL
,	NULL
H.	NULL
Suzuki	NULL
,	NULL
T.	NULL
S.	NULL
Papas	NULL
,	NULL
and	NULL
N.	NULL
K.	NULL
Bhat	NULL
.	NULL

1995	NULL
.	NULL

Role	NULL
of	NULL
ETS1	NULL
in	NULL
IL-2	NULL
gene	NULL
expression	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

154:2724-2732	NULL
.	NULL

Rothenberg	NULL
,	NULL
E.	NULL
,	NULL
and	NULL
S.	NULL
B	NULL
.	NULL

Ward	NULL
.	NULL

1996	NULL
.	NULL

A	NULL
dynamic	NULL
assembly	NULL
of	NULL
diverse	NULL
transcription	NULL
factors	NULL
integrates	NULL
activation	NULL
and	NULL
cell-type	NULL
information	NULL
for	NULL
interleukin	NULL
2	NULL
gene	NULL
regulation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
93:9358-9365	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
F.	NULL
Fritsch	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1989	NULL
.	NULL

Molecular	NULL
cloning	NULL
:	NULL
a	NULL
laboratory	NULL
manual	NULL
,	NULL
2nd	NULL
ed	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
N.Y.	NULL
Schreiber	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
M.	NULL
Miiller	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1988	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
novel	NULL
lymphoid	NULL
specific	NULL
octamer	NULL
binding	NULL
protein	NULL
(	NULL
OTF-2B	NULL
)	NULL
by	NULL
proteolytic	NULL
bandshift	NULL
assay	NULL
(	NULL
PCBA	NULL
)	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

7:4221-4229	NULL
.	NULL

Schreiber	NULL
,	NULL
E.	NULL
,	NULL
P.	NULL
Matthias	NULL
,	NULL
M.	NULL
M.	NULL
Miiller	NULL
,	NULL
and	NULL
W.	NULL
Schaffner	NULL
.	NULL

1989	NULL
.	NULL

Rapid	NULL
detection	NULL
of	NULL
octamer	NULL
binding	NULL
proteins	NULL
with	NULL
``	NULL
miniextracts	NULL
,	NULL
``	NULL
prepared	NULL
from	NULL
a	NULL
small	NULL
number	NULL
of	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

17:6419	NULL
.	NULL

Schwarzenbach	NULL
,	NULL
H.	NULL
,	NULL
J.	NULL
W.	NULL
Newell	NULL
,	NULL
and	NULL
P.	NULL
Matthias	NULL
.	NULL

1994	NULL
.	NULL

Involvement	NULL
of	NULL
the	NULL
ets	NULL
family	NULL
factor	NULL
PU.1	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
immunoglobulin	NULL
promoters	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:898-907	NULL
.	NULL

Serfling	NULL
,	NULL
E.	NULL
,	NULL
A.	NULL
Avots	NULL
,	NULL
and	NULL
M.	NULL
Neumann	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
architecture	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
:	NULL
a	NULL
reflection	NULL
of	NULL
T	NULL
lymphocyte	NULL
activation	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
1263:181-200	NULL
.	NULL

(	NULL
Review	NULL
.	NULL
)	NULL

Serfling	NULL
,	NULL
E.	NULL
,	NULL
R.	NULL
Barthelmiis	NULL
,	NULL
I.	NULL
Pfeuffer	NULL
,	NULL
B.	NULL
Schenk	NULL
,	NULL
S.	NULL
Zarius	NULL
,	NULL
R.	NULL
Swoboda	NULL
,	NULL
F.	NULL
Mercurio	NULL
,	NULL
and	NULL
M.	NULL
Karin	NULL
.	NULL

1989	NULL
.	NULL

Ubiquitous	NULL
and	NULL
lymphocyte-specific	NULL
factors	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
mouse	NULL
interleukin	NULL
2	NULL
gene	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

8:465-473	NULL
.	NULL

Shibasaki	NULL
,	NULL
F.	NULL
,	NULL
E.	NULL
R.	NULL
Price	NULL
,	NULL
D.	NULL
Milan	NULL
,	NULL
and	NULL
F.	NULL
McKeon	NULL
.	NULL

1996	NULL
.	NULL

Role	NULL
of	NULL
kinases	NULL
and	NULL
the	NULL
phosphatase	NULL
calcineurin	NULL
in	NULL
the	NULL
nuclear	NULL
shuttling	NULL
of	NULL
transcription	NULL
factor	NULL
NF-AT4	NULL
.	NULL

Nature	NULL
382:370-373	NULL
.	NULL

Siegel	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
H.	NULL
Yamada	NULL
,	NULL
U.	NULL
R.	NULL
Rapp	NULL
,	NULL
and	NULL
L.	NULL
E.	NULL
Samelson	NULL
.	NULL

1993	NULL
.	NULL

Rapid	NULL
activation	NULL
of	NULL
c-Raf-1	NULL
after	NULL
stimulation	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
or	NULL
the	NULL
muscarinic	NULL
receptor	NULL
type	NULL
1	NULL
in	NULL
resting	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:4116-4127	NULL
.	NULL

Su	NULL
,	NULL
B.	NULL
,	NULL
E.	NULL
Jacinto	NULL
,	NULL
M.	NULL
Hibi	NULL
,	NULL
T.	NULL
Kallunki	NULL
,	NULL
M.	NULL
Karin	NULL
,	NULL
and	NULL
Y.	NULL
Ben-Neriah	NULL
.	NULL

1994	NULL
.	NULL

JNK	NULL
is	NULL
involved	NULL
in	NULL
signal	NULL
integration	NULL
during	NULL
costimulation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

Cell	NULL
77:727-736	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
B.	NULL
,	NULL
C.-Y	NULL
.	NULL

Wang	NULL
,	NULL
I.	NULL
C.	NULL
Ho	NULL
,	NULL
P.	NULL
R.	NULL
Bohjanen	NULL
,	NULL
B.	NULL
Petryniak	NULL
,	NULL
C.	NULL
H.	NULL
June	NULL
,	NULL
S.	NULL
Miesfeldt	NULL
,	NULL
L.	NULL
Zhang	NULL
,	NULL
G.	NULL
J.	NULL
Nabel	NULL
,	NULL
B.	NULL
Karpinski	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1992.	NULL
cis-acting	NULL
sequences	NULL
required	NULL
for	NULL
inducible	NULL
interleukin-2	NULL
enhancer	NULL
function	NULL
bind	NULL
a	NULL
novel	NULL
Ets-related	NULL
protein	NULL
,	NULL
Elf-1	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

12:1043-1053	NULL
.	NULL

Thompson	NULL
,	NULL
C.	NULL
C.	NULL
,	NULL
T.	NULL
A	NULL
.	NULL

Brown	NULL
,	NULL
and	NULL
S.	NULL
L.	NULL
McKnight	NULL
.	NULL

1991	NULL
.	NULL

Convergence	NULL
of	NULL
Ets-	NULL
and	NULL
Notch-related	NULL
structural	NULL
motifs	NULL
in	NULL
a	NULL
heteromeric	NULL
DNA	NULL
binding	NULL
complex	NULL
.	NULL

1991	NULL
.	NULL

Science	NULL
253:762-768	NULL
.	NULL

Treisman	NULL
,	NULL
R.	NULL
1996	NULL
.	NULL

Regulation	NULL
of	NULL
transcription	NULL
by	NULL
MAP	NULL
kinase	NULL
cascades	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:205-215.	NULL
van	NULL
Dam	NULL
,	NULL
H.	NULL
,	NULL
D.	NULL
Wilhelm	NULL
,	NULL
I.	NULL
Herr	NULL
,	NULL
A.	NULL
Steffen	NULL
,	NULL
P.	NULL
Herrlich	NULL
,	NULL
and	NULL
P.	NULL
Angel	NULL
.	NULL

1995	NULL
.	NULL

ATF-2	NULL
is	NULL
preferentially	NULL
activated	NULL
by	NULL
stress-activated	NULL
protein	NULL
kinases	NULL
to	NULL
mediate	NULL
c-jun	NULL
induction	NULL
in	NULL
response	NULL
to	NULL
genotoxic	NULL
agents	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14:1798-1811	NULL
.	NULL

Virbasius	NULL
,	NULL
J.	NULL
V.	NULL
,	NULL
C.-M.	NULL
A.	NULL
Virbasius	NULL
,	NULL
and	NULL
R.	NULL
C.	NULL
Scarpulla	NULL
.	NULL

1993	NULL
.	NULL

Identity	NULL
of	NULL
GABP	NULL
with	NULL
NRF-2	NULL
,	NULL
a	NULL
multisubunit	NULL
activator	NULL
of	NULL
cytochrome	NULL
oxidase	NULL
expres-sion	NULL
,	NULL
reveals	NULL
a	NULL
cellular	NULL
role	NULL
for	NULL
an	NULL
ETS	NULL
domain	NULL
activator	NULL
of	NULL
viral	NULL
promoters	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:380-392	NULL
.	NULL

Wang	NULL
,	NULL
C.-Y	NULL
.	NULL

,	NULL
A.	NULL
G.	NULL
Bassuk	NULL
,	NULL
L.	NULL
H.	NULL
Boise	NULL
,	NULL
C.	NULL
B.	NULL
Thompson	NULL
,	NULL
R.	NULL
Bravo	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Leiden	NULL
.	NULL

1994	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
requires	NULL
cooperative	NULL
binding	NULL
of	NULL
Elf-1	NULL
and	NULL
AP-1	NULL
transcription	NULL
factors	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1153-1159	NULL
.	NULL

Wasylyk	NULL
,	NULL
B.	NULL
,	NULL
S.	NULL
L.	NULL
Hahn	NULL
,	NULL
and	NULL
A.	NULL
Giovane	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
Ets	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Biochem	NULL
.	NULL

211:7-18	NULL
.	NULL

Whitehurst	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
T.	NULL
G.	NULL
Boulton	NULL
,	NULL
M.	NULL
H.	NULL
Cobb	NULL
,	NULL
and	NULL
T.	NULL
D.	NULL
Geppert	NULL
.	NULL

1992	NULL
.	NULL

Extracellular	NULL
signal-regulated	NULL
kinases	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Anti-CD3	NULL
and	NULL
4§-phorbol	NULL
12-myristate	NULL
13-acetate-induced	NULL
phosphorylation	NULL
and	NULL
activation	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:3230-3237	NULL
.	NULL

